{
  "meta": {
    "title": "00100_Mid_Day_Module_Obg-5",
    "url": "https://brainandscalpel.vercel.app/00100-mid-day-module-obg-5-76a4ebe2.html",
    "scrapedAt": "2025-11-29T18:12:55.302Z"
  },
  "questions": [
    {
      "id": 12058,
      "choices": [
        {
          "id": 48196,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with hematometra and hamatocolpos</span></span></span></span></p>"
        },
        {
          "id": 48197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclic pelvic pain is experienced</span></span></span></span></p>"
        },
        {
          "id": 48198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast development is absent/ delayed</span></span></span></span></p>"
        },
        {
          "id": 48199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cruciate incision will relieve symptoms</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old girl presents to OPD and the below examination finding is seen. Which of the following is least likely?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/whatsapp-image-2023-04-29-at-154259.jpeg\" style=\"height:321px; width:300px\" /></span></span></p>",
      "unique_key": "Q4471725",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697542,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Breast development is absent/ delayed</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The finding here is that of an imperforate hymen</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this there is obstructed outflow to menstrual blood which accumulates in the vagina (hematocolpos) and in the uterus (hematometra) and presents as primary amenorrhoea with presence of secondary sexual characters (as the HPO axis is normal) with a bluish bulge at the introitus. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Associated with Hematometra and Hematocolpos</strong>. An imperforate hymen can lead to the hematocolpos and hematometra due to the obstruction of menstrual flow.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cyclic Pelvic Pain is Experienced</strong>: The accumulation of menstrual blood in the vagina and uterus often causes cyclic pelvic pain, which coincides with menstrual cycles , known as cryptomenorrhea.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Breast Development is Absent/Delayed</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Least likely. In cases of imperforate hymen, the hypothalamic-pituitary-ovarian (HPO) axis is intact, and normal secondary sexual characteristics, including breast development, are usually present</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Cruciate Incision will Relieve Symptoms</strong>: A cruciate incision of the hymen is a common surgical intervention to relieve symptoms by allowing the accumulated menstrual blood to drain, thus relieving pain and pressure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In cases of imperforate hymen, patients typically present with symptoms like primary amenorrhea, cyclic pelvic pain, and a bulging hymen due to the accumulation of menstrual blood in the vagina and uterus (hematocolpos and hematometra). These individuals usually have normal secondary sexual development since the hormonal axis is intact. Surgical intervention, such as a cruciate incision of the hymen, is effective in relieving these symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48198,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12060,
      "choices": [
        {
          "id": 48204,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 48205,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 48206,
          "text": "<p><span style=\"font-size:12.0pt;\">MRKH</span></p>"
        },
        {
          "id": 48207,
          "text": "<p><span style=\"font-size:12.0pt;\">Nulliparous prolapse</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 17-year-old girl presents to OPD with cyclic pelvic pain local examination reveals the below image.&nbsp; The diagnosis is?</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture2_D8Jfh1v.jpg\" alt=\"\" width=\"300\" height=\"364\"></span></p>",
      "unique_key": "Q4392056",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697543,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Imperforate hymen</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The finding here is that of an imperforate hymen</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In this there is obstructed outflow to menstrual blood which accumulates in the vagina (hematocolpos) and in the uterus (hematometra) and presents as primary amenorrhoea with presence of secondary sexual characters (as the HPO axis is normal) with a bluish bulge at the introitus.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let's look at the other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Transverse Vaginal Septum</strong>: This is a congenital blockage within the vagina. While it can cause similar symptoms like primary amenorrhea and pelvic pain due to menstrual blood accumulation, <strong>it usually does not present with a bulging, blue perineal membrane as seen in the image.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C.</strong>&nbsp; <strong>Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome</strong>: MRKH syndrome involves congenital absence or underdevelopment of the uterus and vagina. Patients usually present with primary amenorrhea but without cyclic pain or a bulging hymen, as they typically lack functional uterine and upper vaginal tissue.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D</strong>.&nbsp;<strong>Nulliparous Prolapse</strong>: Nulliparous prolapse, or pelvic organ prolapse in a woman who has not given birth, would not present with a bulging, blue membrane at the vaginal entrance and is unrelated to primary amenorrhea or cyclic pelvic pain.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An imperforate hymen presents with primary amenorrhea, cyclic pelvic pain, and a bulging, blue hymenal membrane, indicating hematocolpos (accumulation of menstrual blood in the vagina). This condition can be relieved by surgical incision of the hymen to allow for normal menstrual flow.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorhea</strong></span></p>",
      "correct_choice_id": 48205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12061,
      "choices": [
        {
          "id": 48208,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 48209,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 48210,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian agenesis</span></p>"
        },
        {
          "id": 48211,
          "text": "<p><span style=\"font-size:12.0pt;\">OHVIRA syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 16-year-old girl presents to OPD with primary amenorrhea and cyclic pelvic pain. On rectal examination, a bulge is felt anteriorly, 4 cm above the anal verge. The likely diagnosis is:</span></p>",
      "unique_key": "Q3431357",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697544,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Transverse vaginal septum</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A transverse vaginal septum is the most likely diagnosis as she has primary amenorrhoea with cyclical pelvic pain thereby pointing to a complete obstruction to the outflow of menstrual blood. A rectal exam showing the obstruction high up indicates that the obstruction is higher up in the vagina, thereby pointing to a transverse vaginal septum</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;</strong>Imperforate hymen will have a bulge at the introitus. And on per rectal examination, swelling will be palpable from anal verge.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>MRKH has a vaginal dimple, and no bulge will be felt on per rectal examination</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;</strong>OHVIRA: obstructed hemi vagina and ipsilateral renal agenesis is a syndrome characterized by uterus didelphys, unilateral vaginal obstruction, and ipsilateral renal agenesis. The patient has normal menses from one hemi uterus and features of cyclic pelvic pain and hematocolpos on side of obstructed hemivagina.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-105747.jpg\" alt=\"\" width=\"500\" height=\"527\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Thus <strong>option A.</strong> transverse vaginal septum is correct&nbsp; based on the description ,since the bulge is not at the introitus but higher up.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A transverse vaginal septum presents with primary amenorrhea and cyclic pelvic pain due to hematocolpos formation above the level of the obstruction. Diagnosis is suggested by a normal vaginal orifice and a palpable mass on rectal examination. Recognition and surgical treatment of this congenital anomaly are essential to relieve symptoms and prevent long-term complications.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12062,
      "choices": [
        {
          "id": 48212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OHVIRA syndrome</span></span></span></span></p>"
        },
        {
          "id": 48213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRKH syndrome</span></span></span></span></p>"
        },
        {
          "id": 48214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACUM </span></span></span></span></p>"
        },
        {
          "id": 48215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robert&rsquo;s uterus</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 17-year-old woman presents to OPD with painful menstruation. On examination, normal secondary sexual characters are present. The vagina is patent but shows a bulge on the right side near the cervix. On per rectal examination, there is a bulge felt about 4 cm from anal verge and is more towards left side. On Ultrasound, there is hematocolpos and the left side kidney is absent. </span></span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis is: </span></span></span></span></p>",
      "unique_key": "Q5485439",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697545,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. OHVIRA syndrome</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A. OHVIRA:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">obstructed hemi vagina and ipsilateral renal agenesis is a syndrome characterized by uterus didelphys, unilateral vaginal obstruction, and ipsilateral renal agenesis. The patient has normal menses from one hemi uterus and features of cyclic pelvic pain and hematocolpos on side of obstructed hemivagina. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-105747_O1cNPjD.jpg\" style=\"height:527px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRKH syndrome can have absent kidney / renal and skeletal abnormalities but usually does not have hematocolpos</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACUM is an accessory and cavitated uterine horn. Patients present with dysmenorrhea and features similar to endometriosis. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robert uterus is a rare uterine anomaly with asymmetrical uterine septum resulting in obstructed hemi cavity resulting in hematometra on one side. Patient has normal menses with dysmenorrhea. No bulge in vagina will be felt. On per rectal examination, the bulge may not be palpable as mostly hematometra and hematosalpinx is more likely and there is no hematocolpos. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-110058.jpg\" style=\"height:321px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: OHVIRA syndrome is characterized by a uterine anomaly such as uterine didelphys with obstructed hemivagina leading to hematocolpos, often accompanied by ipsilateral renal agenesis. This syndrome should be considered in patients presenting with painful menstruation, a unilateral vaginal bulge, and corresponding renal anomalies on imaging. Diagnosis and management of OHVIRA syndrome are crucial for alleviating symptoms and addressing potential reproductive complications.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12063,
      "choices": [
        {
          "id": 48216,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete AIS</span></p>"
        },
        {
          "id": 48217,
          "text": "<p><span style=\"font-size:12.0pt;\">Partial AIS</span></p>"
        },
        {
          "id": 48218,
          "text": "<p><span style=\"font-size:12.0pt;\">MRKH</span></p>"
        },
        {
          "id": 48219,
          "text": "<p><span style=\"font-size:12.0pt;\">Swyer syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 18 year old girl presents to OPD with primary amenorrhea, normal breast and pubic &amp; axillary hair development. On examination, vagina is absent. Serum estradiol and FSH level are normal. USG shows absent uterus and vagina. The likely diagnosis is:</span></p>",
      "unique_key": "Q8503163",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697546,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C. MRKH</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This is a case of MRKH (mullerian agenesis) with inguinal hernia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Normal secondary sexual characteristics, absent vagina and absent uterus, normal hormones point towards MRKH.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">They exhibit normal, symmetrical breast and pubic hair development,</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">have no visible vagina and have no symptoms or signs of cryptomenorrhea because the rudimentary uteri contain no functional endometrium.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Renal and skeletal abnormalities may be associated.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The ovaries are entirely normal histologically and functionally, although their location in the pelvis may be higher, positioned at or even above the level of the pelvic brim; one or both also may be hypoplastic or associated with an inguinal hernia. </span><span style=\"background-color:transparent;font-size:16px;\">Inguinal hernia is rare in MRKH, but known due to ectopic ovaries</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Complete Androgen Insensitivity Syndrome (AIS)</strong>: In complete AIS, individuals have a 46,XY karyotype and testes, but due to a complete inability to respond to androgens, they develop female external genitalia. However, they typically have normal breast development <strong>but no pubic or axillary hair</strong>. The presence of normal pubic and axillary hair development makes complete AIS less likely in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Partial AIS</strong>: Partial AIS involves some degree of androgen insensitivity, leading to a spectrum of genital ambiguity. The presence of normal female secondary sexual characteristics and an inguinal hernia may be consistent with partial AIS, but the absent uterus and vagina are not typical for this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;D.</strong>&nbsp;<strong>Swyer Syndrome</strong>: Swyer syndrome, or 46XY pure gonadal dysgenesis, presents with a 46XY karyotype and streak gonads but with female external genitalia. Individuals typically have primary amenorrhea and underdeveloped secondary sexual characteristics due to the lack of functional ovaries. The presence of normal breast development and pubic/axillary hair makes this diagnosis less likely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">In cases of primary amenorrhea with normal female secondary sexual characteristics and the absence of the uterus and vagina, Mayer-Rokitansky-Küster-Hauser syndrome is a likely diagnosis. MRKH syndrome is characterized by the congenital absence of the uterus and upper vagina while maintaining normal ovarian function and external secondary sexual characteristics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48218,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12064,
      "choices": [
        {
          "id": 48220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty</span></span></span></span></p>"
        },
        {
          "id": 48221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty, and IVF with self-oocyte and surrogacy</span></span></span></span></p>"
        },
        {
          "id": 48222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty and IVF with donor oocyte and surrogacy</span></span></span></span></p>"
        },
        {
          "id": 48223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty and donor embryo and surrogacy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old girl presents to OPD with primary amenorrhea and evaluation reveals MRKH. Treatment for patients with MRKH includes: </span></span></span></span></p>",
      "unique_key": "Q4673613",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697547,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Vaginoplasty, and IVF with self-oocyte and surrogacy</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The 2 goals of treatment in MRKH syndrome are: Sexual function and Fertility</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual function</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creation of a functional vagina. This can be achieved</span></span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgically &ndash; McIndoe&rsquo;s vaginoplasty</span></span></span></span></li>\r\n\t\t\t<li style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-surgical: Using vaginal dilators (Fran dilators)</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fertility</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Advances in assisted reproductive technologies with the use of gestational surrogacy option have allowed attainment of genetic offspring by in vitro fertilization (IVF) using oocytes retrieved from their own normal ovaries and the sperm of their chosen partner, with subsequent transfer of embryos to a gestational surrogate.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the past decade, uterine transplantation has moved leaps and bounds, may emerge as a treatment option.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Let&#39;s look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vaginoplasty</strong>: This treatment alone does not address the issue of fertility, as these patients typically lack a functional uterus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vaginoplasty, and IVF with Self-Oocyte and Surrogacy</strong>: Correct. This option includes vaginoplasty to create a vagina and the use of in vitro fertilization (IVF) with the patient&#39;s own oocytes. Because women with MRKH typically have normal ovaries, they can produce eggs for IVF. The fertilized embryos can then be carried by a surrogate mother, as patients with MRKH lack a uterus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Vaginoplasty and IVF with Donor Oocyte and Surrogacy</strong>: This option is not typically necessary for MRKH patients, as they usually have functional ovaries and can use their own oocytes for IVF. The use of donor oocytes would be considered if there were an issue with the patient&#39;s egg quality or quantity.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Vaginoplasty and Donor Embryo and Surrogacy</strong>: Similar to option C, this approach would only be necessary if there were issues with the patient&#39;s oocytes. As women with MRKH generally have normal ovarian function, they can typically use their own oocytes for IVF.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: For patients with MRKH syndrome, treatment can include vaginoplasty to construct a functional vagina and IVF using self-oocytes, with the embryo being carried by a surrogate mother. This approach addresses both the anatomical challenge of the absent vagina and the issue of fertility due to the absence of a functional uterus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12065,
      "choices": [
        {
          "id": 48224,
          "text": "<p><span style=\"font-size:12.0pt;\">Karyotype will most likely be 46XX</span></p>"
        },
        {
          "id": 48225,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with renal and skeletal anomalies</span></p>"
        },
        {
          "id": 48226,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadectomy and vaginoplasty are recommended treatment</span></p>"
        },
        {
          "id": 48227,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate Gonadectomy is done immediately</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old girl presents to OPD with primary amenorrhea. Height is 160 cm, has normal breast development and absent pubic hair. The uterus and vagina are absent. Which of the following is true?</span></p>",
      "unique_key": "Q4930693",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. Gonadectomy and vaginoplasty are recommended treatment</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The presented case is of Androgen Insensitivity Syndrome</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Patients with complete AIS most commonly present after the age of puberty in late adolescence or as young adults with primary amenorrhea. They exhibit asymmetrical secondary sexual development (breast development with absent or scant pubic hair), have a short vagina with no visible cervix, and have no other symptoms or complaints.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Serum testosterone concentration easily distinguishes patients with AIS from those with Müllerian agenesis because levels are normal or modestly elevated well above the normal range for females and often above the range observed in normal males. Serum LH levels also are elevated, reflecting androgen insensitivity at the hypothalamus-pituitary level. A karyotype (46XY) firmly establishes the diagnosis.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In patients with AIS, the options for creation of a neovagina are the same as for those with Müllerian agenesis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Complete AIS is the only exception to the rule that gonads with a Y chromosome should be removed as soon as the diagnosis is made.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let's evaluate each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Karyotype will most likely be 46XX</strong>: False. The presence of normal breast development and absent pubic hair suggests Androgen Insensitivity Syndrome (AIS), where the karyotype is typically 46XY. Mullerian agenesis will have pubic hair development</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Associated with renal and skeletal anomalies</strong>: False. While renal and skeletal anomalies are commonly associated with MRKH syndrome, they are not a typical feature of Androgen Insensitivity Syndrome (AIS). Mullerian agenesis will have pubic hair development</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Gonadectomy and Vaginoplasty are recommended treatment</strong>: Correct for AIS. Patients with complete AIS have testes that produce normal to high levels of testosterone, which gets converted to estrogen, leading to breast development. However, the body is insensitive to testosterone, resulting in scant or absent pubic hair. Gonadectomy is recommended to prevent the risk of gonadal tumors. Vaginoplasty may be performed for the creation of a functional vagina.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Immediate Gonadectomy is done immediately</strong>: Immediate gonadectomy is not typically recommended in complete AIS. It is usually delayed until after puberty to allow for natural estrogen production from the testes, which contributes to female secondary sexual characteristics. Incomplete AIS may require earlier gonadectomy due to a higher risk of gonadal tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In Androgen Insensitivity Syndrome (AIS), which is characterized by a 46XY karyotype, patients typically present with primary amenorrhea, normal breast development, and scant pubic hair due to insensitivity to androgens. Gonadectomy is recommended to prevent gonadal tumor risk, often after puberty to benefit from endogenous estrogen production for sexual development. Vaginoplasty is an option for those who wish to have a functional vagina.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12067,
      "choices": [
        {
          "id": 48232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal anomalies</span></span></span></span></p>"
        },
        {
          "id": 48233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal anomalies</span></span></span></span></p>"
        },
        {
          "id": 48234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inguinal hernia </span></span></span></span></p>"
        },
        {
          "id": 48235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoromegaly</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old girl presents to OPD with primary amenorrhea, she has normal breast development and scant pubic hair. Labia minora are small and vagina is absent. Which of the following is most likely to be associated with this: </span></span></p>",
      "unique_key": "Q5561905",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697549,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Inguinal hernia </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical picture is of complete AIS. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The gonads are testes, and their location may be intra-abdominal, but often are partially descended into the inguinal canal, more than half of patients with complete AIS have an inguinal hernia, and the testes are frequently palpable in the inguinal canals, most commonly at the level of the external inguinal ring.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal Anomalies</strong>: They are more commonly associated with conditions like Mayer-Rokitansky-K&uuml;ster-Hauser (MRKH) syndrome, not typically with Complete Androgen Insensitivity Syndrome (AIS).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Skeletal Anomalies</strong>: Also seen more frequently in MRKH syndrome not in AIS. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inguinal Hernia</strong>: Correct. In Complete AIS, the individual has a 46XY karyotype with testes that may be located in the inguinal canal, leading to a higher likelihood of inguinal hernias. More than half of patients with Complete AIS have an inguinal hernia, and the testes are often palpable in the inguinal canals.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Clitoromegaly</strong>: Clitoromegaly is more commonly associated with conditions that involve exposure to higher levels of androgens, such as Congenital Adrenal Hyperplasia (CAH). It is not typically a feature of Complete AIS, where there is insensitivity to androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In Complete Androgen Insensitivity Syndrome (AIS), patients with a 46,XY karyotype present with female external genitalia, normal breast development, and absent or scant pubic hair due to insensitivity to androgens. A common associated condition is the presence of inguinal hernias, as the testes may be located in the inguinal canal. Understanding the clinical presentation and associated features of Complete AIS is essential for accurate diagnosis and appropriate management.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12071,
      "choices": [
        {
          "id": 48248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46 XX</span></span></span></span></p>"
        },
        {
          "id": 48249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XY</span></span></span></span></p>"
        },
        {
          "id": 48250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45 X0</span></span></span></span></p>"
        },
        {
          "id": 48251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">47 XXY</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14-year-old girl presents to OPD with primary amenorrhea. Her height is 135 cm. She has a webbed neck and increased carrying angle. Breast development is tanner 1 with widely spaced nipple, external genitalia are infantile. The Karyotype is most likely to reveal: </span></span></p>",
      "unique_key": "Q7273216",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697550,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. 45 X0</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a case of Turner syndrome. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Short stature, widely spaced nipple, short fourth metacarpals, increased carrying angle are typical features of Turner syndrome. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype is 45X0. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mosaics of 45X0/46XX or 45 X0/46XY may exist. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>46 XX</strong>: Normal female karyotype. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>46 XY</strong>: Normal male karyotype. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>47 XXY</strong>: This karyotype is associated with Klinefelter syndrome, which is characterized by a male phenotype with some level of hypogonadism and gynecomastia, not matching the clinical presentation described in the girl.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In a patient presenting with primary amenorrhea, short stature, webbed neck, widely spaced nipples, and infantile external genitalia, the karyotype most likely to be found is 45 X0, indicative of Turner syndrome. Turner syndrome is characterized by the absence of all or part of a second sex chromosome, leading to various developmental and physical abnormalities. Identification of this condition is crucial for appropriate management and support.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12073,
      "choices": [
        {
          "id": 48256,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen therapy</span></p>"
        },
        {
          "id": 48257,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclic Estrogen and progesterone therapy</span></p>"
        },
        {
          "id": 48258,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone and Estrogen therapy</span></p>"
        },
        {
          "id": 48259,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone and cyclic Estrogen-progesterone therapy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 13-year-old girl with primary amenorrhea, short stature, and hypergonadotropic hypogonadism. Karyotype reveals 45X0. What is the next line of management?</span></p>",
      "unique_key": "Q4934599",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697551,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C. Growth hormone and Estrogen therapy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">With early diagnosis and treatment with growth hormone (GH), a final height greater than 150 cm can be achieved in most patients with Turner syndrome.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The most important determinants of final height are the dose of GH and the duration of treatment before estrogen therapy begins.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Treatment with GH generally should begin as soon as growth curve falls below the fifth percentile of normal female growth, and the regimen must be individualized, according to response.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Treatment with estrogen must be timed carefully, with the goals of minimizing its adverse effects on growth and adult height and inducing puberty at an approximately normal age.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Ideally, estrogen therapy should begin no later than age 15 and not before age 12 when growth is a priority, unless height already has been maximized.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Estrogen therapy should begin at a low dose (e.g., 0.25-0.5 mg micronized oestradiol or its equivalent), increasing gradually at intervals of 3-6 months according to response (Tanner stage, bone age), with the goal of completing sexual maturation over a period of 2-3 years.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>When vaginal bleeding first occurs, or after 12-24 months of estrogen therapy, a progestin (e.g., MPA) should be added to the treatment regimen to prevent dysfunctional bleeding, to achieve differentiation of breast tissue, and to protect the endometrium from long-term adverse effects of unopposed estrogen</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Let's explore each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Estrogen Therapy</strong>: Estrogen therapy is used in Turner syndrome to induce secondary sexual characteristics and maintain female sex hormone levels. However, initiating estrogen therapy alone may not address short stature, a common issue in Turner syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;B</strong>.&nbsp;<strong>Cyclic Estrogen and Progesterone Therapy</strong>: This therapy is appropriate for inducing and maintaining secondary sexual characteristics and menstrual cycles. However, it does not address the short stature associated with Turner syndrome. </span><span style=\"background-color:transparent;font-size:16px;\">Full HRT is used later after height is optimized.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;C.</strong>&nbsp;<strong>Growth Hormone and Estrogen Therapy</strong>: Correct. Growth hormone therapy is recommended to address short stature in Turner syndrome. It should ideally begin as early as possible, and estrogen therapy should be initiated carefully to induce puberty without adversely affecting growth.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;D</strong>.&nbsp;<strong>Growth Hormone and Cyclic Estrogen-Progesterone Therapy</strong>: While this combination addresses both growth and the development of secondary sexual characteristics, the initiation of cyclic estrogen-progesterone therapy may be deferred until after maximizing height with growth hormone therapy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">For a patient with Turner syndrome presenting with short stature and primary amenorrhea, the recommended management includes growth hormone therapy to address short stature and estrogen therapy to induce secondary sexual characteristics. The timing and dosage of estrogen therapy are critical to balance the induction of puberty with the potential impact on growth. Growth hormone therapy should ideally begin when the growth curve falls below the fifth percentile, and estrogen therapy should start between the ages of 12 and 15, gradually increasing over time</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48258,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12075,
      "choices": [
        {
          "id": 48264,
          "text": "<p><span style=\"font-size:12.0pt;\">Karyotype</span></p>"
        },
        {
          "id": 48265,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclic Estrogen and progesterone</span></p>"
        },
        {
          "id": 48266,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadectomy</span></p>"
        },
        {
          "id": 48267,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginoplasty</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 17-year-old girl presents to OPD for not having attained menses till now. On examination, height is 170 cm, breasts are not well developed, pubic hair are absent, external genitalia are normal and vagina and uterus are present. Serum FSH is high. What is the next step?</span></p>",
      "unique_key": "Q6172086",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697552,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Karyotype</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The clinical picture is of Swyer syndrome. (46XY dysgenesis)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">But to differentiate it from 46 XX gonadal dysgenesis or premature ovarian failure, a karyotype must be done before proceeding with gonadectomy.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Karyotype</strong>: Correct. Given the clinical presentation, a karyotype test is essential to determine the chromosomal pattern, which will help in diagnosing conditions like Swyer syndrome (46,XY gonadal dysgenesis) or other forms of gonadal dysgenesis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B</strong>.&nbsp;<strong>Cyclic Estrogen and Progesterone</strong>: Hormone replacement therapy with estrogen and progesterone may be necessary to induce secondary sexual characteristics and regular menstrual cycles, but it should only be initiated after a definitive diagnosis is made via karyotyping.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Gonadectomy</strong>: Gonadectomy may be indicated in cases of Swyer syndrome due to the increased risk of gonadoblastoma in streak gonads. However, this should only be considered after a definitive diagnosis is confirmed through karyotyping.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D</strong>.&nbsp;<strong>Vaginoplasty</strong>: Vaginoplasty is a surgical procedure to create or reconstruct a vagina. This is not indicated in this case, as the patient has a normal vagina and external genitalia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>: In a patient with primary amenorrhea, underdeveloped breasts, and elevated serum FSH, karyotyping is the next essential step to differentiate between conditions like Swyer syndrome (46,XY gonadal dysgenesis) and other forms of gonadal dysgenesis. This will guide further management, including the possibility of hormone replacement therapy or gonadectomy, depending on the diagnosis</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref:&nbsp;Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12076,
      "choices": [
        {
          "id": 48268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen insensitivity syndrome</span></span></span></span></p>"
        },
        {
          "id": 48269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Constitutional delay</span></span></span></span></p>"
        },
        {
          "id": 48270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional hypothalamic amenorrhoea</span></span></span></span></p>"
        },
        {
          "id": 48271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mullerian agenesis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16y girl is brought to the OPD as she has not started her period. The patients 14y sister underwent menarche 2 years earlier and her mother began menstruating at age 13. She has no weight gain, headaches, nipple discharge or abdominal pain. She is not sexually active and is not using any method of contraception. She is physically active and is on her school&rsquo;s basketball team. Her breast exam and pubic hair are Tanner stage IV. The abdomen is soft. The external genitalia appear normal. The vagina ends in a blind pouch. An ultrasound reveals ovaries, but no cervix or uterus is seen. Which is the most likely diagnosis?</span></span></span></span></p>",
      "unique_key": "Q1834105",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697553,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Mullerian agenesis</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mullerian agenesis is also known as MRKH syndrome</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is no Mullerian structure (Absent uterus, cervix, fallopian tubes, upper 2/3<sup>rd</sup> of vagina) but ovaries are present</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So patient presents as primary amenorrhoea with normal secondary sexual characters</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All hormonal levels are normal</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal and renal anomalies may be associated</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype: 46XX</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fertility: Surrogacy, uterine transplant (upcoming)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual: Vaginoplasty</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Androgen Insensitivity Syndrome</strong>: 46XY karyotype develop female external genitalia due to androgen receptor insensitivity. However, breast development is usually normal or above average due to peripheral conversion of androgens to estrogens. The presence of Tanner stage IV breast development and pubic hair is less typical for AIS, which usually presents with scant or absent pubic hair.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Constitutional Delay</strong>: A variation of normal development where puberty and associated milestones, such as menarche, occur later than average. However, the presence of Tanner stage IV breast development and pubic hair indicates that puberty has progressed, making this less likely.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Functional Hypothalamic Amenorrhea: This</strong> is associated with stress, significant weight loss, or excessive exercise and results in suppressed gonadotropin-releasing hormone (GnRH) secretion. This diagnosis is less likely given the patient&#39;s normal development of secondary sexual characteristics and absence of weight loss or other stress factors.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In a patient with primary amenorrhea, normal secondary sexual development, and a blind-ending vaginal pouch with absent uterus and cervix on ultrasound, M&uuml;llerian agenesis is the most likely diagnosis. This condition is characterized by the congenital absence of the uterus and part of the vagina while maintaining normal ovarian function and external genitalia. Diagnosis is crucial for appropriate management and support.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12097,
      "choices": [
        {
          "id": 48352,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B, C, D, E</span></span></p>"
        },
        {
          "id": 48353,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B, C, D</span></span></p>"
        },
        {
          "id": 48354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B</span></span></p>"
        },
        {
          "id": 48355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A,B,D</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year female presents to OPD with secondary amenorrhea. She does not bleed on the progesterone challenge or even after giving her a course of combined estrogen and progesterone pills. Asherman syndrome is suspected. This can result from. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Curettage</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tuberculosis </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine artery embolization</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cesareans section</span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical biopsy</span></span></li>\r\n</ol>",
      "unique_key": "Q7339584",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697554,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. A, B, C, D</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option :</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Curettage</span></strong>: Asherman syndrome is often a result of trauma to the uterine lining, most commonly due to aggressive curettage, especially postpartum or post-abortion curettage.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis</span></strong>: Genital tuberculosis, particularly uterine tuberculosis, can lead to the development of intrauterine adhesions, contributing to Asherman syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine Artery Embolization</span></strong>: Uterine artery embolization, typically used to treat uterine fibroids, can cause damage to the endometrium and lead to the formation of intrauterine adhesions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cesarean Section</span></strong>: Though less common, Asherman syndrome can occur post-cesarean section if there is endometrial damage during the surgery, leading to scar formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. E.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical Biopsy</span></strong>: A cervical biopsy is less likely to cause intrauterine scarring compared to the procedures listed in the other options.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most comprehensive and accurate answer for the causes of Asherman syndrome in the given options would be <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. A, B, C, D</span></strong>, which encompasses curettage, tuberculosis, uterine artery embolization, and cesarean section.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman syndrome is typically caused by intrauterine trauma or surgery (like curettage or uterine artery embolization), certain infections (like genital tuberculosis), and less commonly by cesarean sections. Understanding these causes is essential for preventing and managing Asherman syndrome, which can lead to secondary amenorrhea and infertility</span></span></span></p>\r\n\r\n<p style=\"margin-left:68px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Asherman syndrome is intrauterine adhesions or synechiae</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">They arise due to</span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Surgical trauma to the uterus which may be seen following</span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dilatation and curettage (esp sharp curettage)</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cesarean section</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myomectomy where the endometrial cavity is involved</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metroplasty</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Trans-cervical resection of the endometrium</span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine artery embolization</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endometrial ablative procedures </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intra-uterine infections like tuberculosis and schistosomiasis</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">But the classical history is usually after a D &amp; C, the patient develops amenorrhoea</span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Symptoms:</span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hypomenorrhea</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Secondary amenorrhoea </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Secondary infertility</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Diagnosis</span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">On ultrasound:</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">On HSG</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intra-uterine filling defects are seen giving a moth-eaten appearance</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hysteroscopy</span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#3d3d3d\">Gold standard for diagnosis</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#3d3d3d\">Treatment:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#3d3d3d\">Hysteroscopic adhesiolysis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\">Post procedure:</span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\">&nbsp;To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\">Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. </span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#3d3d3d\">Ref: Page 1080, William&rsquo;s gynecology, 3<sup>rd</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 48353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12099,
      "choices": [
        {
          "id": 48360,
          "text": "<p><span style=\"font-size:12pt;\">PCOS</span></p>"
        },
        {
          "id": 48361,
          "text": "<p><span style=\"font-size:12pt;\">Asherman syndrome</span></p>"
        },
        {
          "id": 48362,
          "text": "<p><span style=\"font-size:12pt;\">Cervical stenosis</span></p>"
        },
        {
          "id": 48363,
          "text": "<p><span style=\"font-size:12pt;\">Gonadal dysgenesis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 30-year-old female presents to OPD with secondary amenorrhea for 2 years. She has 2 living issues and has undergone two surgical abortions in the past Her BMI is 30 kg/m2. She has no withdrawal bleeding after progesterone or after estrogen and progesterone. The likely cause is:</span></p>",
      "unique_key": "Q4647856",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697555,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B. Asherman syndrome</strong></span></p><p style=\"margin-left:48px;text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Let us look at the other options:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. A.</strong>&nbsp;<strong>Polycystic Ovary Syndrome (PCOS)</strong>: PCOS is characterized by irregular menstrual cycles, signs of hyperandrogenism (such as hirsutism or acne), and polycystic ovaries on ultrasound. However, women with PCOS typically have some bleeding in response to progesterone due to built-up endometrial lining, making this answer less likely</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. C.</strong>&nbsp;<strong>Cervical Stenosis</strong>: Cervical stenosis refers to the narrowing of the cervical canal. It can cause amenorrhea by physically blocking the passage of menstrual blood. However, in cervical stenosis, the endometrium typically responds to hormonal stimulation and there may be some evidence of trapped blood or hematometra on imaging, distinguishing it from Asherman syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. D.</strong>&nbsp;<strong>Gonadal Dysgenesis</strong>: Gonadal dysgenesis, such as Turner syndrome or Swyer syndrome, typically presents with primary amenorrhea and underdeveloped secondary sexual characteristics, not secondary amenorrhea.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Asherman syndrome, characterized by the formation of intrauterine adhesions or scars, typically presents with secondary amenorrhea and a lack of withdrawal bleeding after hormonal challenges. It is often a result of uterine surgery or trauma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>About Asherman Syndrome:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The diagnosis of Asherman syndrome is based primarily on a high index of suspicion, based on history. In women whose history suggests this possibility, scant or no withdrawal bleeding after sequential treatment with exogenous estrogen and progestin reflects end-organ endometrial failure and corroborates the clinical suspicion.</span></p></li><li><span style=\"font-size:12pt;\">Asherman syndrome is intra uterine adhesions.</span></li><li><span style=\"font-size:12pt;\">They arise due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Surgical trauma to the uterus which may be seen following</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Dilatation and curettage (esp sharp curettage)</span></li><li><span style=\"font-size:12pt;\">Cesarean section</span></li><li><span style=\"font-size:12pt;\">Myomectomy where the endometrial cavity is involved</span></li><li><span style=\"font-size:12pt;\">Metroplasty</span></li><li><span style=\"font-size:12pt;\">Trans-cervical resection of the endometrium</span></li></ul></li><li><span style=\"font-size:12pt;\">Uterine artery embolization</span></li><li><span style=\"font-size:12pt;\">Endometrial ablative procedures</span></li><li><span style=\"font-size:12pt;\">Intra-uterine infections like tuberculosis and schistosomiasis</span></li></ul></li><li><span style=\"font-size:12pt;\">Symptoms:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\">Hypomenorrhea</span></li><li><span style=\"font-size:12pt;\">Secondary amenorrhoea</span></li><li><span style=\"font-size:12pt;\">Secondary infertility</span></li></ul></li><li><span style=\"font-size:12pt;\">Diagnosis</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\">On ultrasound</span></li></ul></li><li><span style=\"font-size:12pt;\">Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</span></li><li><span style=\"font-size:12pt;\">On HSG</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Intra-uterine filling defects are seen giving a moth-eaten appearance</span></li></ul></li><li><span style=\"font-size:12pt;\">Hysteroscopy</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Gold standard for diagnosis</span></li></ul></li><li><span style=\"font-size:12pt;\">Treatment:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Hysteroscopic adhesiolysis</span></li><li><span style=\"font-size:12pt;\">Post procedure:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">&nbsp;To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</span></li><li><span style=\"font-size:12pt;\">Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12101,
      "choices": [
        {
          "id": 48368,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sheehan syndrome</span></span></p>"
        },
        {
          "id": 48369,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Asherman syndrome</span></span></p>"
        },
        {
          "id": 48370,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Premature ovarian insufficiency</span></span></p>"
        },
        {
          "id": 48371,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Polycystic Ovarian syndrome</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old P2L2 woman who has undergone a tubal ligation comes to the OPD with amenorrhea 2 years after her ligation. Her FSH is high. Which of the following is the likely diagnosis: </span></span></p>",
      "unique_key": "Q1917737",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697556,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Premature ovarian insufficiency</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Premature ovarian failure/ or premature ovarian insufficiency is hypergonadotropic hypogonadism and amenorrhea occurring before the age of 40 years. </span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sheehan syndrome and Asherman syndrome will not have raised FSH</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PCOS will have reversed LH:FSH ratio, have other pointers for diagnosis of PCOS (like the hyperandrogenism or ultrasound morphology suggestive of PCOS)</span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan Syndrome</span></strong>: Sheehan syndrome is caused by pituitary gland damage due to severe blood loss and hypovolemic shock during or after childbirth. It typically presents with low levels of pituitary hormones, not elevated FSH. This condition would cause hypogonadotropic hypogonadism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman Syndrome</span></strong>: Asherman syndrome is characterized by intrauterine adhesions or scarring and is often a result of uterine surgery. While it can cause amenorrhea, it does not typically result in elevated FSH levels, as the issue is structural rather than ovarian.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic Ovarian Syndrome (PCOS)</span></strong>: PCOS is characterized by irregular menstrual cycles, signs of hyperandrogenism, and polycystic ovaries. PCOS typically involves normal or low FSH levels and does not usually lead to primary ovarian failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Premature ovarian insufficiency (POI) is characterized by the loss of normal ovarian function before the age of 40, presenting as amenorrhea with elevated FSH levels, indicative of hypergonadotropic hypogonadism. It is important to consider POI in women under 40 presenting with amenorrhea and high FSH levels, as it has implications for fertility and overall health</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></strong></span></span></p>",
      "correct_choice_id": 48370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12102,
      "choices": [
        {
          "id": 48372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">OCP</span></span></p>"
        },
        {
          "id": 48373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cabergoline</span></span></p>"
        },
        {
          "id": 48374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dexamethasone</span></span></p>"
        },
        {
          "id": 48375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oxytocin</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to OPD with complaint of secondary amenorrhea. On examination, there is galactorrhoea, and her prolactin levels are high. Urine pregnancy test is negative. Which of the following is treatment of choice for her: </span></span></span></p>",
      "unique_key": "Q4689067",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697557,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Cabergoline</strong></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is a scenario of hyperprolactinemia which commonly presents as galactorrhoea and oligomenorrhoea (Delayed cycles)</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dopamine agonists are the first line treatment for hyperprolactinemia. Bromocriptine and cabergoline are first line treatments. </span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral Contraceptive Pills (OCP)</span></strong>: OCPs are used to regulate menstrual cycles and provide contraception</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></strong>: is a steroid used in the treatment of various conditions, including some endocrine disorders, but it is not a first-line treatment for hyperprolactinemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxytocin</span></strong>: Oxytocin is a hormone that stimulates uterine contractions and milk ejection in lactation</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The treatment of choice for hyperprolactinemia, which often presents with galactorrhoea and secondary amenorrhea, is dopamine agonists such as cabergoline or bromocriptine. These medications effectively lower prolactin levels, which can help restore normal menstrual function and resolve galactorrhoea</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></strong></span></span></p>",
      "correct_choice_id": 48373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12104,
      "choices": [
        {
          "id": 48380,
          "text": "<p><span style=\"font-size:12pt;\">Asherman syndrome</span></p>"
        },
        {
          "id": 48381,
          "text": "<p><span style=\"font-size:12pt;\">Sheehan syndrome</span></p>"
        },
        {
          "id": 48382,
          "text": "<p><span style=\"font-size:12pt;\">PCOS</span></p>"
        },
        {
          "id": 48383,
          "text": "<p><span style=\"font-size:12pt;\">Primary ovarian insufficiency</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 30 y comes to OPD for evaluation of absent periods. The patient had a vaginal delivery 8 months ago and she’s not had her period since delivery. Her postpartum course was complicated by atonic PPH requiring massive blood transfusion. At a visit, 2 months ago, the patient was started on combined OCPs, and she has not had vaginal bleeding. Prior to this pregnancy she had regular monthly cycles. She also has increased fatigue. She is not lactating and is bottle feeding her baby. There is no headache, galactorrhoea, or hot flushes. BMI is 31, vitals are normal. Pelvic examination shows clear vaginal discharge and well rugate vagina. The uterus is small and anteverted. UPT is negative. TSH levels are elevated. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q4036944",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B. Sheehan Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Etiopathogenesis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">During pregnancy, the <strong>pituitary gland enlarges</strong> due to hyperplasia of lactotrophs.</span></li><li><span style=\"font-size:16px;\">In the setting of <strong>severe blood loss or hypotension</strong> during/after delivery, the <strong>enlarged pituitary is vulnerable to ischemia</strong>.</span></li><li><span style=\"font-size:16px;\">Leads to <strong>necrosis of pituitary tissue</strong>, resulting in <strong>partial or complete hypopituitarism</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Early signs:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Failure to lactate (due to ↓ prolactin)</span></li><li><span style=\"font-size:16px;\">Prolonged amenorrhea or oligomenorrhea</span></li><li><span style=\"font-size:16px;\">Fatigue, hypotension</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Late signs:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Loss of secondary sexual hair (pubic/axillary)</span></li><li><span style=\"font-size:16px;\">Cold intolerance, dry skin (↓ TSH)</span></li><li><span style=\"font-size:16px;\">Hypoglycemia, weight loss (↓ ACTH, cortisol)</span></li><li><span style=\"font-size:16px;\">Infertility</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Diagnosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">History of <strong>severe PPH</strong> with failure to resume normal postpartum function</span></li><li><span style=\"font-size:16px;\">Hormonal assays: ↓ levels of <strong>prolactin, ACTH, TSH, LH, FSH, GH</strong></span></li><li><span style=\"font-size:16px;\"><strong>MRI of pituitary</strong> may show an empty sella or hypoplastic gland</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Treatment:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Lifelong hormone replacement therapy</strong>, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Glucocorticoids</strong> (hydrocortisone)</span></li><li><span style=\"font-size:16px;\"><strong>Levothyroxine</strong></span></li><li><span style=\"font-size:16px;\"><strong>Estrogen/progesterone</strong> (if fertility not desired)</span></li><li><span style=\"font-size:16px;\"><strong>Gonadotropins</strong> (if fertility desired)</span></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Let us look at the other options:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A.</strong> <strong>Asherman syndrome</strong>: Asherman syndrom<strong>e</strong> is a condition characterized by intrauterine adhesions or synechiae, often resulting from trauma to the endometrium, typically after dilation and curettage. It leads to menstrual abnormalities (amenorrhea or hypomenorrhea), infertility, and recurrent pregnancy loss. Diagnosis is confirmed by hysteroscopy, and treatment involves surgical adhesiolysis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. C.</strong>&nbsp;<strong>Polycystic Ovary Syndrome (PCOS)</strong>: PCOS is an endocrine disorder characterized by irregular menstrual cycles, signs of hyperandrogenism, and polycystic ovaries. While the patient has an elevated BMI, a common feature in PCOS, the absence of her periods following a complicated postpartum course and the absence of typical PCOS symptoms make this diagnosis less likely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. D.</strong>&nbsp;<strong>Primary Ovarian Insufficiency</strong>: Primary ovarian insufficiency, also known as premature ovarian failure, involves early depletion of ovarian follicles and usually presents with elevated FSH levels, which is not the case here.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Asherman syndrome, characterized by intrauterine adhesions or scarring typically following uterine surgery or trauma, is the most likely cause of secondary amenorrhea in a patient with a history of postpartum hemorrhage and D&amp;C. The diagnosis is supported by the absence of menstrual bleeding even with hormonal stimulation and a history suggestive of intrauterine injury.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:16px;\">Asherman syndrome is intra uterine adhesions, they arise due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Surgical trauma to the uterus which may be seen following</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:16px;\">Dilatation and curettage (esp. sharp curettage)</span></li><li><span style=\"font-size:16px;\">Cesarean section</span></li><li><span style=\"font-size:16px;\">Myomectomy where the endometrial cavity is involved</span></li><li><span style=\"font-size:16px;\">Metroplasty</span></li><li><span style=\"font-size:16px;\">Trans-cervical resection of the endometrium</span></li></ul></li><li><span style=\"font-size:16px;\">Uterine artery embolization</span></li><li><span style=\"font-size:16px;\">Endometrial ablative procedures</span></li><li><span style=\"font-size:16px;\">Intra-uterine infections like tuberculosis and schistosomiasis</span></li></ul></li><li><span style=\"font-size:16px;\">Symptoms:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Hypomenorrhea</span></li><li><span style=\"font-size:16px;\">Secondary amenorrhoea</span></li><li><span style=\"font-size:16px;\">Secondary infertility</span></li></ul></li><li><span style=\"font-size:16px;\">Diagnosis</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">On ultrasound</span></li></ul></li><li><span style=\"font-size:16px;\">Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</span></li><li><span style=\"font-size:16px;\">On HSG</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Intra-uterine filling defects are seen giving a moth-eaten appearance</span></li></ul></li><li><span style=\"font-size:16px;\">Hysteroscopy</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Gold standard for diagnosis</span></li></ul></li><li><span style=\"font-size:16px;\">Treatment:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Hysteroscopic adhesiolysis</span></li><li><span style=\"font-size:16px;\">Post procedure:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:16px;\">&nbsp;To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</span></li><li><span style=\"font-size:16px;\">Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12106,
      "choices": [
        {
          "id": 48388,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated luteinizing hormone (LH) level</span></span></p>"
        },
        {
          "id": 48389,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated gonadotropin-releasing hormone (GnRH) level</span></span></p>"
        },
        {
          "id": 48390,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated leptin level</span></span></p>"
        },
        {
          "id": 48391,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated neuropeptide Y level</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old with previously regular menses, presents with amenorrhea. She is also diagnosed with anorexia nervosa. Which of the following is likely to be seen in this patient?</span></span></p>",
      "unique_key": "Q8081570",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697559,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Elevated neuropeptide Y level</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In anorexia nervosa, there is Hypogonadotrophic hypogonadism</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The FSH, LH levels are reduced and so are the estrogen levels</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Various biologic actors have been implicated in eating disorder development</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Abnormalities in neuropeptides, neurotransmitters, and hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes are reported </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients with anorexia nervosa have been found to have low circulating leptin levels</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It has been hypothesized that a decrease in leptin production due to weight loss could secondarily stimulate neuropeptide Y, which is known to stimulate hunger and alter GnRH pulsatility.</span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option. A.</strong>&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Luteinizing Hormone (LH) Level</span></strong>: Incorrect. In anorexia nervosa, there is typically hypogonadotropic hypogonadism, characterized by low levels of gonadotropins, including LH. This is due to the body&#39;s response to starvation and undernutrition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Gonadotropin-Releasing Hormone (GnRH) Level</span></strong>: Incorrect. GnRH levels are often reduced in anorexia </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Leptin Level</span></strong>: Incorrect. Leptin, a hormone produced by adipose tissue, is typically low in anorexia nervosa due to the loss of body fat. Low leptin levels are associated with reduced energy intake and weight loss.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Neuropeptide Y Level</span></strong>: Correct. Neuropeptide Y is involved in the regulation of appetite and is known to stimulate hunger. In anorexia nervosa, the decrease in leptin due to weight loss can lead to an increase in neuropeptide Y as a compensatory mechanism to stimulate appetite. Additionally, neuropeptide Y can alter GnRH pulsatility, contributing to menstrual irregularities.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In anorexia nervosa, there is typically hypogonadotropic hypogonadism with reduced levels of LH, FSH, and estrogen. Low circulating leptin levels due to weight loss can stimulate neuropeptide Y, which affects appetite regulation and GnRH pulsatility. This hormonal dysregulation contributes to the development of amenorrhea in patients with anorexia nervosa.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 404, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></p>",
      "correct_choice_id": 48391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12109,
      "choices": [
        {
          "id": 48400,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients typically present with amenorrhea. </span></span></p>"
        },
        {
          "id": 48401,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is the most common cause of chronic anovulation. </span></span></p>"
        },
        {
          "id": 48402,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is characterized by hypogonadotropic hypogonadism.</span></span></p>"
        },
        {
          "id": 48403,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is characterized by persistently elevated follicle stimulating hormone (FSH) and oestradiol levels</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding polycystic ovarian syndrome?</span></span></p>",
      "unique_key": "Q1043930",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. It is the most common cause of chronic anovulation. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is syndrome is by far the most common cause of chronic anovulation</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Women with PCOS have different menstrual patterns</span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amenorrhoea due to anovulation</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Heavy menstrual bleeding and intermenstrual bleeding can result from unopposed estrogen stimulation of the endometrium</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In PCOS</span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LH &gt; FSH</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oestradiol levels are usually normal</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Let&#39;s evaluate each statement regarding polycystic ovarian syndrome (PCOS):</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients typically present with amenorrhea</span></strong>: While amenorrhea can occur in PCOS, it&#39;s more common for patients to present with irregular menstrual cycles or oligomenorrhea rather than complete absence of menstruation. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the most common cause of chronic anovulation</span></strong>: Correct. This chronic anovulation contributes to irregular menstrual cycles and infertility, both hallmark symptoms of PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by hypogonadotropic hypogonadism</span></strong>: This is incorrect. PCOS is actually characterized by hyperandrogenism (excess male hormones) and is not typically associated with hypogonadotropic hypogonadism. In fact, women with PCOS often have normal or slightly elevated levels of gonadotropins like LH.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by persistently elevated follicle stimulating hormone (FSH) and oestradiol levels</span></strong>: This statement is not accurate for PCOS. In PCOS, FSH levels are usually normal or slightly lower, not persistently elevated. The hormonal hallmark of PCOS is an elevated LH to FSH ratio, along with elevated levels of androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Polycystic ovarian syndrome (PCOS) is the most common cause of chronic anovulation and is characterized by symptoms such as irregular menstrual cycles, hyperandrogenism, and polycystic ovaries. Understanding PCOS&#39;s clinical presentation and hormonal profile is essential for diagnosis and management.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 406, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></p>",
      "correct_choice_id": 48401,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12112,
      "choices": [
        {
          "id": 48412,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Adrenal hyperplasiaI</span></p>"
        },
        {
          "id": 48413,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Idiopathic hirsutism</span></p>"
        },
        {
          "id": 48414,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic Ovarian Syndrome</span></p>"
        },
        {
          "id": 48415,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone secreting tumor</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old girl presents to the OPD with excess facial hair for 6 months and delayed menstrual cycles. On evaluation, levels of free testosterone are increased. An ultrasound reveals normal uterus and normal ovaries on USG. The most likely diagnosis is?</span></p>",
      "unique_key": "Q1275961",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697561,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. Polycystic Ovarian Syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic ovarian syndrome/ disease (PCOS/PCOD) is a disorder of chronically abnormal ovarian function (oligo/anovulation) and hyperandrogenism frequently associated with hyperinsulinemia and insulin resistance, resulting in menstrual irregularity, infertility, and hirsutism.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Rotterdam 2003 criteria is used to diagnose&nbsp; PCOS/PCOD:&nbsp;As per this criterion, at least 2 of 3 should be present:</strong></span></p><ol style=\"list-style-type:decimal;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Oligo/anovulation (causes oligomenorrhea, 20<sup> </sup>amenorrhea, and infertility)</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Hyperandrogenism: Biochemical or clinical (increased serum androgens or acne, hirsutism)</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>12 or more than 12 follicle 2-9 mm in size present within 1 or both ovaries on USG and/or ovarian volume &gt; 10 mL (pearl necklace pattern).</strong></span></p></li></ol></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture9_0mgVKz8.jpg\" alt=\"\" width=\"300\" height=\"204\"></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">USG appearance of polycystic ovaries</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">As the patient in the question satisfies first 2 criteria, she is a case of PCOS</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>let's consider the other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adrenal Hyperplasia</strong>: Adrenal hyperplasia, particularly congenital adrenal hyperplasia (CAH), can cause symptoms similar to PCOS, including hirsutism and menstrual irregularities, due to elevated androgens. However, it is usually diagnosed earlier in life and often has other associated adrenal hormone abnormalities.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Idiopathic Hirsutism</strong>: Idiopathic hirsutism refers to hirsutism (excess hair growth) in the absence of any identifiable hormonal imbalance or ovarian/adrenal gland disorder. Given the increased free testosterone levels in this patient, idiopathic hirsutism is less likely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Testosterone Secreting Tumor</strong>: While a testosterone-secreting tumor can cause increased androgen levels and symptoms like hirsutism, these tumors are rare. The more common presentation of such tumors would include rapid onset of symptoms and <strong>markedly elevated testosterone levels.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic Ovarian Syndrome (PCOS) is the most likely diagnosis in a young woman presenting with hirsutism, menstrual irregularities, and elevated free testosterone levels. The diagnosis of PCOS is based on a combination of clinical, biochemical, and ultrasound findings, and it is important to consider this condition in women with such symptoms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 401, Speroff’s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12113,
      "choices": [
        {
          "id": 48416,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 48417,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">b, d, e</span></p>"
        },
        {
          "id": 48418,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">a, b, e</span></p>"
        },
        {
          "id": 48419,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c, d</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is correct about polycystic ovarian disease (PCOD)?</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Testosterone&gt; 2 ng/ml</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Infertility</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">High FSH/LH ratio</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fasting glucose/ insulin ratio &gt; 4.5</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic appearance on 1 or both ovaries on ultrasound</span></p></li></ol>",
      "unique_key": "Q9724069",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. b, d, e</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">PCOS includes chronic non ovulation, hyperandrogenism associated with normal or raised estradiol level (E2), raised LH0 &amp; low FSH/LH ratio.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Diagnosis:&nbsp;</strong>Diagnosis is based upon the presence of any two of the following three criteria (Rotterdam Criteria)</span></p><ol style=\"list-style-type:decimal;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Oligomenorrhoea/or anovulation (Delayed cycles and infertility)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hyperandrogenism (Clinical &amp;/or biochemical)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic ovaries (Ultrasound finding of 1 OR both ovaries)</span></p></li></ol></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">On investigations,&nbsp;</span></p><ul style=\"list-style-type:circle;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">LH: FSH ratio is increased (3:1) i.e. LH is more than FSH</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Increase free testosterone levels</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Increase DHEAS</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fasting glucose: insulin ratio &lt; 4.5</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sex hormone binding globulin decreases</span></p></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Possible late sequelae of PCOD are:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Risk of developing diabetes mellitus (15%) due to insulin resistance</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Risk of developing endometrial carcinoma due to elevated level of estrogen.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Risk of hypertension &amp; cardiovascular disease due w abnormal lipid profile (dyslipidaemia)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at each option</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. A.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Testosterone &gt; 2 ng/ml</strong>: Elevated testosterone levels are a hallmark of PCOS, reflecting the condition's hyperandrogenic state. However, a level &gt; 2 ng/ml is quite high and not a typical threshold for PCOS diagnosis. Elevated testosterone in PCOS is usually more modest.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Infertility</strong>: Correct. Infertility is a common complication of PCOS due to chronic anovulation (lack of ovulation). Many women with PCOS struggle with infertility or subfertility.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>High FSH/LH Ratio</strong>: This is incorrect. In PCOS, the LH to FSH ratio is often elevated (reversed), not the FSH to LH ratio. A common finding is an LH to FSH ratio greater than 2:1.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Fasting Glucose/Insulin Ratio &gt; 4.5</strong>: Correct. &nbsp;While insulin resistance is a feature of PCOS, this specific ratio is not a standard diagnostic criterion for the condition. PCOS is often associated with insulin resistance, but diagnostic criteria typically don't include a specific fasting glucose/insulin ratio.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option E.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Polycystic Appearance on 1 or Both Ovaries on Ultrasound</strong>: Correct. One of the diagnostic criteria for PCOS, according to the Rotterdam criteria, is the presence of polycystic ovaries on ultrasound, characterized by 12 or more follicles measuring 2-9 mm in diameter, or an increased ovarian volume (&gt;10 cm³) in one or both ovaries.</span></p><p style=\"text-align:justify;\"><br><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic ovarian disease (PCOD/PCOS) is characterized by features such as hyperandrogenism (e.g., elevated testosterone levels), infertility due to chronic anovulation, and polycystic ovaries on ultrasound. Understanding these features is key in the diagnosis and management of PCOS.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 411, Speroff’s clinical gynaecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48417,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12115,
      "choices": [
        {
          "id": 48424,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marked elevation of LH in contrast to FSH</span></span></span></span></p>"
        },
        {
          "id": 48425,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin resistance</span></span></span></span></p>"
        },
        {
          "id": 48426,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevation of plasma testosterone</span></span></span></span></p>"
        },
        {
          "id": 48427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevation in the levels of sex hormone binding globulin (SHBG)</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The biochemical chaanges in established cases of Stein-Leventhal syndrome are all except?</span></span></p>",
      "unique_key": "Q8938157",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697563,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Elevation in the levels of sex hormone binding globulin (SHBG)</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stein Leventhal syndrome is the older name of PCOS</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In PCOS (Stein Leventhal syndrome) the levels of SHBG decrease</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other features of PCOS are</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LH: FSH ratio is increased (3:1) i.e. LH is more than FSH</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase free testosterone levels. </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase DHEAS</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fasting glucose: insulin ratio &lt; 4.5</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sex hormone binding globulin decreases.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s examine each statement:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marked elevation of LH in contrast to FSH</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. In PCOS, there is often a marked elevation of LH relative to FSH, leading to an increased LH:FSH ratio. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin Resistance</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. Insulin resistance is a common finding in PCOS, contributing to its pathophysiology. It is associated with an increased risk of type 2 diabetes and other metabolic complications in these patients.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Elevation of Plasma Testosterone</strong>: Correct. Hyperandrogenism, characterized by elevated levels of testosterone, is a hallmark of PCOS. This leads to symptoms such as hirsutism, acne, and androgenic alopecia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevation in the Levels of Sex Hormone Binding Globulin (SHBG)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. In PCOS, there is typically a decrease in the levels of SHBG. Lower levels of SHBG result in increased bioavailability of testosterone, contributing to the hyperandrogenic symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In PCOS, biochemical changes include an elevated LH:FSH ratio, insulin resistance, increased levels of plasma testosterone, and decreased levels of SHBG. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 411 Speroff&rsquo;s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48427,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12117,
      "choices": [
        {
          "id": 48432,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovaries</span></span></span></span></p>"
        },
        {
          "id": 48433,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></span></span></p>"
        },
        {
          "id": 48434,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pelvic inflammatory disease</span></span></span></span></p>"
        },
        {
          "id": 48435,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most likely diagnosis in a 28-year-old obese woman presenting with Oligomenorrhea, infertility and hirsutism?</span></span></span></span></p>",
      "unique_key": "Q6892119",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697564,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Polycystic ovaries</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young woman presenting in the third decade with obesity, oligomenorrhea, infertility and hirsutism leaves no doubt for the diagnosis of PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to Rotterdam criteria &rarr; PCOD is diagnosed if any 2 of 3 of the following criteria are being fulfilled:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovulatory dysfunction such as oligomenorrhea or hyperandrogenism.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical or biochemical evidence of hyperandrogenism</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">USG criteria (1 or both ovaries showing polycystic appearance)</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since this woman has oligomenorrhea and hirsutism, SO2 of the criteria are being fulfilled.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is a condition where endometrial tissue grows outside the uterus. It commonly presents with painful periods, chronic pelvic pain, and can be associated with infertility. However, it does not typically present with hirsutism or oligomenorrhea as primary symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pelvic Inflammatory Disease (PID)</strong>: PID is an infection of the female reproductive organs, often caused by sexually transmitted infections. It typically presents with pelvic pain, fever, and abnormal vaginal discharge.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing Syndrome</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cushing syndrome is caused by prolonged exposure to high levels of cortisol. It can present with obesity, menstrual irregularities, and hirsutism. However, the other symptoms of Cushing&#39;s syndrome (like a round face, high blood pressure, and purple stretch marks) are not mentioned, making PCOS a more likely diagnosis in this case.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Polycystic Ovary Syndrome (PCOS) should be highly suspected in women presenting with a combination of oligomenorrhea, infertility, hirsutism, and often obesity. PCOS is a complex endocrine disorder that impacts multiple aspects of health and is a common cause of infertility in women.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 400, Speroff&rsquo;s clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48432,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12118,
      "choices": [
        {
          "id": 48436,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">17-OH progesterone</span></p>"
        },
        {
          "id": 48437,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">DHEA</span></p>"
        },
        {
          "id": 48438,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Testosterone</span></p>"
        },
        {
          "id": 48439,
          "text": "<p><span style=\"font-size:12.0pt;\">LH: FSH ratio</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Preeti, a 20-year-old girl presents with a history of rapidly developing hirsutism, severe acne and amenorrhea. Her BMI is 19. To establish the diagnosis, which would be the most appropriate blood test?</span></p>",
      "unique_key": "Q3941819",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697565,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C. Testosterone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">For cases of virilisation and hirsutism, serum testosterone is the investigation of choice</span></p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">A variety of ovarian neoplasms, both benign and malignant may produce testosterone and lead to virilization. Specifically, women with an abrupt onset, typically within several months, or sudden worsening of virilizing signs should prompt concern for a hormone producing ovarian or adrenal tumour.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Symptoms may include deepening of voice, frontal balding, severe acne, or hirsutism or both, increased muscle mass and clitoromegaly.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Accordingly, serum testosterone levels may be used to exclude these tumours. Free testosterone levels are more sensitive than total testosterone levels as an indicator of hyperandrogenism.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">\"Threshold values beyond 200 ng/dl of total testosterone warrant evaluation for an ovarian lesion\".</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Testosterone estimation is the best investigation in case of rapid onset hirsutism and amenorrhea.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">M/C cause of rapid onset hirsutism in young females = Testosterone producing tumour</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">DHEA sulphate is produced exclusively by the adrenal gland. Therefore, serum DHEAS levels above 700 mcg/dl are highly sensitive&nbsp;for the presence of an adrenal neoplasm.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Adrenal imaging with abdominal CT or MRI is indicated for any patient with DHEAS levels that exceed this value.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Let us look at each option separately:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. A.</strong> <strong>17-OH Progesterone</strong>: This test is used to evaluate adrenal gland function and diagnose congenital adrenal hyperplasia (CAH), a condition that can cause symptoms similar to PCOS, including hirsutism and menstrual irregularities. However, the rapid onset of symptoms described is less typical for CAH.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. B.</strong> <strong>DHEA (Dehydroepiandrosterone)</strong>: DHEA is an androgen produced by the adrenal glands. While elevated levels can contribute to hirsutism and acne, DHEA alone may not provide a definitive diagnosis in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C.</strong>&nbsp;<strong>Testosterone</strong>: Correct. Elevated levels of testosterone are a key indicator of hyperandrogenism, which can manifest as hirsutism, acne, and menstrual irregularities. Measuring testosterone levels is crucial in diagnosing conditions like PCOS or androgen-secreting tumors, which can present with rapid onset of symptoms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. D.</strong> <strong>LH: FSH Ratio</strong>: This ratio is often evaluated in the diagnosis of PCOS, as women with PCOS may have an elevated ratio. However, <strong>a normal ratio does not rule out PCOS, and it is not as directly indicative of hyperandrogenism as elevated testosterone levels.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">When evaluating a young woman with rapid onset of hirsutism, severe acne, and amenorrhea, measuring serum testosterone levels is crucial for diagnosing conditions associated with hyperandrogenism, such as PCOS or androgen-secreting tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ref: Page 449, Speroff’s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48438,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12120,
      "choices": [
        {
          "id": 48444,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomenorrhea</span></span></span></span></p>"
        },
        {
          "id": 48445,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sonographic polycystic appearance of ovaries</span></span></span></span></p>"
        },
        {
          "id": 48446,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral distribution of follicles on transvaginal ultrasonography</span></span></span></span></p>"
        },
        {
          "id": 48447,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical signs of hyperandrogenism</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not included in Rotterdam criteria?</span></span></p>",
      "unique_key": "Q6164420",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697566,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Peripheral distribution of follicles on transvaginal ultrasonography</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomenorrhea/ anovulation</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical or biochemical sign of hyperandrogenism</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound features of polycystic ovaries</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound&nbsp;features which are considered for diagnosis of polycystic ovaries includes the presence of these in one or both ovaries</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ge;12 follicles measuring 2&ndash;9 mm throughout the entire ovary.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased ovarian volume of &gt; 10 cm3</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A single ovary complying these features is sufficient for diagnosing as polycystic <strong>ovaries(PCO) </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us evaluate each option to identify which is not included in these criteria:</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomenorrhea</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Included. Oligomenorrhea, or infrequent menstrual periods, is one of the criteria under the Rotterdam guidelines for diagnosing PCOS. It reflects the chronic anovulation commonly seen in PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sonographic Polycystic Appearance of Ovaries</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Included. The presence of polycystic ovaries on ultrasound is a part of the Rotterdam criteria. This is typically defined as having 12 or more follicles in each ovary measuring 2-9 mm in diameter, or increased ovarian volume.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Peripheral Distribution of Follicles on Transvaginal Ultrasonography</strong>: Not included. While the presence of multiple follicles is a criterion, the specific pattern of their distribution, such as a peripheral arrangement, is not a requirement for the diagnosis of PCOS as per the Rotterdam criteria.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical Signs of Hyperandrogenism</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Included. Clinical signs of hyperandrogenism, such as hirsutism, acne, or androgenic alopecia, are part of the Rotterdam criteria. Alternatively, biochemical signs of hyperandrogenism can also fulfill this criterion.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Rotterdam criteria for the diagnosis of PCOS include at least two of the following: oligomenorrhea or amenorrhea, clinical or biochemical signs of hyperandrogenism, and polycystic ovaries on ultrasound. The specific distribution pattern of ovarian follicles is not a part of these diagnostic criteria.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 400, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12121,
      "choices": [
        {
          "id": 48448,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases LH production</span></span></span></span></p>"
        },
        {
          "id": 48449,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces production of FSH</span></span></span></span></p>"
        },
        {
          "id": 48450,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acts on androgen receptors and antagonizes it</span></span></span></span></p>"
        },
        {
          "id": 48451,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces ovarian androgen production</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 19y girl with PCOS is started on the combination pill shown below. What is the role of the progesterone component of this combination?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture10.jpg\" style=\"height:177px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q9835423",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697567,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Reduces ovarian androgen production</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen production in PCOD women usually is an LH-dependent process. PROGESTINS in oral contraceptives suppress pituitary LH secretion and thus also suppress ovarian androgen production.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Progestin in oral contraceptives inhibit 5&alpha; reductase activity in skin which decreases the production of dihydrotestosterone (DHT), the major nuclear androgen in hair follicles and sebaceous glands.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s consider the role of the progesterone component:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases LH Production</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. Progestins in oral contraceptive pills (OCPs), including Drosperinone, do not increase LH production. Instead, they help suppress ovulation partly by inhibiting the release of gonadotropins like LH from the pituitary gland.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces Production of FSH</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Progestins contribute to the suppression of FSH production, which is a mechanism involved in preventing ovulation. However, this is not the most direct effect of drospirenone in the context of PCOS treatment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acts on Androgen Receptors and Antagonizes it</strong>: Drosperinone has anti-androgenic properties, meaning it can counteract the effects of androgens. This action helps reduce symptoms like acne and hirsutism in PCOS but is not its primary mechanism of action in terms of ovarian androgen production.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces Ovarian Androgen Production</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. One of the key roles of drospirenone in OCPs for PCOS is to reduce ovarian androgen production. By suppressing gonadotropin release (LH and FSH), drospirenone reduces the stimulation of the ovaries, leading to decreased production of androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In the treatment of PCOS, Drosperinone in combination oral contraceptive pills helps reduce ovarian androgen production by suppressing gonadotropin release. This action not only aids in regulating the menstrual cycle but also helps in managing hyperandrogenic symptoms such as acne and hirsutism commonly seen in PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 420, Speroff&rsquo;s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48451,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12122,
      "choices": [
        {
          "id": 48452,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic alopecia</span></span></span></span></p>"
        },
        {
          "id": 48453,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased facial hair</span></span></span></span></p>"
        },
        {
          "id": 48454,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoromegaly</span></span></span></span></p>"
        },
        {
          "id": 48455,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following features are seen in PCOS except?</span></span></span></span></p>",
      "unique_key": "Q5053520",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697568,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Clitoromegaly</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features seen in PCOD are:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic alopecia</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased facial hair</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menstrual irregularity</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In PCOD there is increased androgen production which is LH mediated and lead to growth of terminal hairs on the face or body in a male pattern</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoromegaly is not seen in PCOD.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism defined as excessive male pattern facial and body hair</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Virilization is defined by the signs and symptoms of more severe androgen excess which include deepening of voice, clitoromegaly, balding and breast atrophy.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hair is characterized as <strong>vellus</strong> that is fine, soft, and unpigmented or <strong>terminal </strong>i.e long, coarse and pigmented</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In androgen sensitive areas androgen stimulates growth of longer, thicker, and darker hairs.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hair follicles testosterone needs to be converted to dihydrotestosterone by 5&alpha; reductase. Dihydrotestosterone is the main hormone which plays a crucial role in hair growth.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Let us look at each option</strong>:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic Alopecia: Seen&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in PCOS. Androgenic alopecia, or male-pattern hair loss, can occur in PCOS due to the effects of elevated androgens on hair follicles.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased Facial Hair</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Seen in PCOS. Hirsutism, or increased facial and body hair in a male pattern, is a common feature of PCOS, resulting from increased androgen levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clitoromegaly</strong>: Not seen in PCOS. Clitoromegaly, or an enlarged clitoris, is a sign of virilization and is more indicative of conditions with severe androgen excess, such as congenital adrenal hyperplasia or androgen-secreting tumors. It is not a characteristic feature of PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Seen in PCOS. Acne is a common dermatological manifestation in PCOS, also related to elevated androgen levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Polycystic ovary syndrome (PCOS) is characterized by signs of hyperandrogenism, such as hirsutism, acne, and androgenic alopecia, along with menstrual irregularities. Clitoromegaly is not a typical feature of PCOS and is more indicative of conditions with more severe androgen excess. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 449, Speroff&rsquo;s Clinical Gynaecological Endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12124,
      "choices": [
        {
          "id": 48460,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Insulin resistance</span></p>"
        },
        {
          "id": 48461,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Cushing syndrome</span></p>"
        },
        {
          "id": 48462,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Androgen producing tumors</span></p>"
        },
        {
          "id": 48463,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital adrenal hyperplasia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"background-color:transparent;font-size:16px;\">During evaluation of PCOS, a serum 17 –hydroxyprogesterone levels of 800 ng/dl was obtained. This value warrants the diagnosis of?</span></p>",
      "unique_key": "Q3245742",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697569,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D. Congenital adrenal hyperplasia</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">CONGENITAL ADRENAL HYPERPLASIA is caused by adrenal enzyme deficiency of most commonly 21 hydroxylase that results in excessive adrenal androgen production.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Non classical or late onset CAH present later during life with signs of hyperandrogenism, very much like in PCOD.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Specific testing for CAH is usually reserved for those having early onset hirsutism (pre or peri-menarchal), women with family history of disorder and high-risk ethnic groups like Ashkenazi Jews.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A follicular phase morning serum 17 OHP concentration less than 200ng/dl, excludes and a level greater than 800 ng/dl establishes the diagnosis of CAH.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Between values of 200-800 ACTH stimulation test needs to be done with intramuscular injection of 0.25 mg ACTH , if the 17 OHP concentration will rise above 1500 mg/dL, it is diagnostic for CAH.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at each option</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Insulin Resistance</strong>: Insulin resistance is a common feature of PCOS but is not directly indicated by elevated 17-hydroxyprogesterone levels. Insulin resistance is typically assessed through glucose tolerance tests or measurements of fasting insulin levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cushing Syndrome</strong>: Cushing syndrome is characterized by excessive cortisol production. While it can present with features like PCOS, such as weight gain and menstrual irregularities, elevated 17-hydroxyprogesterone is not a typical finding in Cushing's.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Androgen Producing Tumors</strong>: Androgen-producing tumors can cause symptoms similar to PCOS. However, elevated 17-hydroxyprogesterone levels are more indicative of adrenal disorders like congenital adrenal hyperplasia rather than androgen-producing tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Congenital Adrenal Hyperplasia (CAH)</strong>: Correct. Elevated levels of 17-hydroxyprogesterone are a key indicator for congenital adrenal hyperplasia, particularly the 21-hydroxylase deficiency form. In the context of PCOS evaluation, an abnormally high level of 17-hydroxyprogesterone warrants further investigation to exclude CAH.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">When evaluating a patient for PCOS, a significantly elevated level of 17-hydroxyprogesterone, as in this case, suggests the need to exclude congenital adrenal hyperplasia, especially the 21-hydroxylase deficiency variant. CAH can mimic many symptoms of PCOS, including hyperandrogenism and menstrual irregularities.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page 449, Speroff’s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48463,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12125,
      "choices": [
        {
          "id": 48464,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Male pattern hair growth on lower abdomen</span></p>"
        },
        {
          "id": 48465,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Thickened dark skin on inner thighs</span></p>"
        },
        {
          "id": 48466,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Abnormal glucose tolerance test results</span></p>"
        },
        {
          "id": 48467,
          "text": "<p><span style=\"color:black;font-size:12pt;\">High serum levels of high-density lipoproteins</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 19-year-old girl with a long-standing history of irregular menstrual cycles and amenorrhea presents with an ultrasound picture shown below. Which of the following is least likely to be seen in her?</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture11_c5RSZPQ.jpg\" alt=\"\" width=\"300\" height=\"229\"></span></p>",
      "unique_key": "Q4546560",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697570,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D.&nbsp;High serum levels of high-density lipoproteins</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">PCOD&nbsp;women shows chronic anovulation and commonly shows insulin resistance which is associated with acanthosis and thickening of skin.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Insulin resistance leads to abnormal glucose tolerance detected using GTT with 75 gm glucose.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Upto10% of women with PCOS develop diabetes by age 40.</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Metabolic abnormalities in PCOD</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Elevated androgen level leads to increased LDL levels</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Increased triglyceride levels (&gt;150mg/dl)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Normal or decreased HDL levels(&lt;50mg/dl)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hyperinsulinemia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Central obesity with increased waist circumference (&gt;88 cm)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let consider each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. A.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Male Pattern Hair Growth on Lower Abdomen</strong>: Likely. Hirsutism, or male pattern hair growth, is a common feature in PCOS due to hyperandrogenism. This can include hair growth on the lower abdomen.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Thickened Dark Skin on Inner Thighs</strong>: Likely. Acanthosis nigricans, characterized by thickened and darkened skin, often in areas like the neck and inner thighs, is commonly associated with insulin resistance, a condition often seen in PCOS.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Abnormal Glucose Tolerance Test Results</strong>: Likely. Women with PCOS are at increased risk for insulin resistance and type 2 diabetes. An abnormal glucose tolerance test is a common finding and reflects impaired insulin sensitivity.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>High Serum Levels of High-Density Lipoproteins (HDL)</strong>: Least likely. PCOS is often associated with a dyslipidemic profile, which typically includes lower levels of HDL (\"good\" cholesterol) and higher levels of LDL (\"bad\" cholesterol) and triglycerides. <strong>High levels of HDL are not characteristic of the metabolic disturbances commonly seen in PCOS.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">PCOS is often associated with signs of hyperandrogenism like hirsutism, metabolic issues such as insulin resistance and abnormal glucose tolerance, and a dyslipidemic profile with lower HDL levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ref: Page 400, Speroff’s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48467,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12128,
      "choices": [
        {
          "id": 48476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pancreas</span></span></span></span></p>"
        },
        {
          "id": 48477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Adrenal</span></span></span></span></p>"
        },
        {
          "id": 48478,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ovary</span></span></span></span></p>"
        },
        {
          "id": 48479,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pituitary</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During detailed workup of PCOD in a 19-year-old patient shown below is noted to have a serum total testosterone level of 375 ng/dl with rapidly increasing hirsutism. Which of the following endocrine glands is likely to harbour the androgen producing tumour?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture12_CA3vfPf.jpg\" style=\"height:195px; width:250px\" /></span></span></span></p>",
      "unique_key": "Q6129644",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp; Ovary </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shown is hirsutism. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When the serum total testosterone concentration (&gt;150ng/dl) or the clinical presentation suggests the possibility of rare androgen producing ovarian or adrenal tumours, remember that ovarian tumours are more common than adrenal tumours</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen secreting tumours of the ovary include</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertoli-Leydig tumours</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lipid cell tumours</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theca cell tumours</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brenners tumour</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Transvaginal ultrasound is gold standard to detect such tumour.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal tumours are identified by adrenal CT.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most androgen producing adrenal tumours are malignant.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Adrenal adenomas are smaller than carcinoma and have smooth borders. CT features of irregular margin, necrosis, haemorrhage, or calcification suggest a carcinoma.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selective ovarian venous catheterization can be considered for the rare patient having no demonstrable ovarian or adrenal mass lesion.</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s consider the potential source of an androgen-producing tumour:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreas</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The pancreas is not typically a source of androgen-producing tumours. It primarily functions in insulin and digestive enzyme production, and its pathologies are not usually associated with elevated androgen levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Adrenal tumours can produce androgens, leading to symptoms like hirsutism. However, ovarian tumours are more common causes of elevated androgens in women. Adrenal tumours are less frequent and are usually identified with adrenal CT imaging.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ovary</strong>: Correct. Ovarian tumours, such as Sertoli-Leydig cell tumours, lipid cell tumours, theca cell tumours, or Brenner tumours, can secrete high levels of androgens. Given the high serum testosterone level and the clinical presentation, an ovarian source is more likely than an adrenal source. Transvaginal ultrasound is typically used for initial evaluation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ption. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pituitary</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pituitary tumours, such as prolactinomas or adenomas producing ACTH, can affect menstrual cycles and hormonal balance, but they are not known for directly secreting androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In cases of PCOD with significantly elevated serum testosterone levels and rapidly increasing hirsutism, an androgen-secreting ovarian tumour should be considered. Ovarian tumours are a more common source of excess androgens in women compared to adrenal tumours. Transvaginal ultrasound is the gold standard for detecting such ovarian tumours, while adrenal tumours are identified with adrenal CT imaging</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 449, Speroff&rsquo;s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41601,
      "choices": [
        {
          "id": 166088,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1b 2d 3c 4a</span></span></span></p>"
        },
        {
          "id": 166089,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1a 2d 3c 4b</span></span></span></p>"
        },
        {
          "id": 166090,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1a 2c 3d 4b</span></span></span></p>"
        },
        {
          "id": 166091,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1b 2c 3d 4a</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following correctly:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113312.JPG\" style=\"height:201px; width:700px\" /></span></span></p>",
      "unique_key": "Q1352958",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697572,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. 1a 2d 3c 4b</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Remember this very important table</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113640.JPG\" style=\"height:737px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Remember this very important table</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113640_kvczIXj.JPG\" style=\"height:737px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: DC Dutta&rsquo;s Textbook of Contraception</span></strong></span></span></p>",
      "correct_choice_id": 166089,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41602,
      "choices": [
        {
          "id": 166092,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Disappearance of the Mullerian duct</span></span></span></p>"
        },
        {
          "id": 166093,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Differentiation of the Wolffian duct</span></span></span></p>"
        },
        {
          "id": 166094,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Differentiation of the gonad into the testes</span></span></span></p>"
        },
        {
          "id": 166095,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Disappearance of the ovary</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of the SRY gene will cause what important development in embryology?</span></span></p>",
      "unique_key": "Q5791449",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697573,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Differentiation of the gonad into the testes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal Sex Development</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sex development starts in utero and continues in adult life with attainment of sexual maturity and reproductive capability</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Major determinants of sex development are</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosomal Sex (46XX or 46XY)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadal sex (Testes or ovary)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phenotypic sex (External genitalia)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sex determination primarily begins by the presence or absence of the Y chromosome </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">On the Short arm of the Y chromosome, there is located the SRY gene (Sex Determining Region) &ndash; Yp11.3 and is the most important genetic aspect for sex determination and its presence or absence determines the direction of gonadal differentiation. </span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SRY activates several other genes that promote testis development. These include</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SOX 9</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fgf 9</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In 46 XX embryos, genes responsible include Wnt4 and Rspo 1.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The chromosomal sex determines the gonadal sex (i.e. whether the gonads will become testes or ovaries) in the embryo. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY </span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">On the Short arm of the Y chromosome, there is located the SRY gene (Sex Determining Region) &ndash; Yp11.3 and is the most important genetic aspect for sex determination and its presence or absence determines the direction of gonadal differentiation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SRY activates several other genes that promote testis development.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 166094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41603,
      "choices": [
        {
          "id": 166096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 weeks</span></span></span></p>"
        },
        {
          "id": 166097,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">6 weeks</span></span></span></p>"
        },
        {
          "id": 166098,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">7 weeks</span></span></span></p>"
        },
        {
          "id": 166099,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">8 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A curious pregnant patient visits the antenatal OPD. She has missed her period by 4 days and her pregnancy test is positive. This is her 1<sup>st</sup> pregnancy and although, sex detection is banned in India, she is very curious about how the baby forms and asks if it is possible to know the sex of the baby now. You tell her that the gonads are undifferentiated at present. The gonads are bipotent till?</span></span></p>",
      "unique_key": "Q1792887",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697574,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. 5 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113705.JPG\" style=\"height:204px; width:845px\" /></span></strong></span></span></p>",
      "correct_choice_id": 166096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41604,
      "choices": [
        {
          "id": 166100,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">45 XO gonadal dysgenesis</span></span></span></p>"
        },
        {
          "id": 166101,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">46 XX gonadal dysgeneses</span></span></span></p>"
        },
        {
          "id": 166102,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">46 XY gonadal dysgenesis</span></span></span></p>"
        },
        {
          "id": 166103,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">46 XXY gonadal dysgenesis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Swyer syndrome is an example of</span></span></span></p>",
      "unique_key": "Q1603829",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697575,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. 46 XY gonadal dysgenesis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">46 XY Complete gonadal dysgenesis (Swyer syndrome)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uncommon form of gonadal dysgenesis; 46XY karyotype</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The dysgenetic gonads don&rsquo;t produce AMH/ Androgens, so Phenotype is female. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They have a normal uterus, fallopian tubes, cervix and vagina</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No masculinization of external genitalia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">15% mutation of SRY gene</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Majority: No cause identified</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Present as</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary amenorrhoea</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Delayed sexual maturation</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal pubic hair</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal female internal and external genitalia</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypogonadotrophic hypogonadism</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Karyotype</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sex of assignment and rearing: Female</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadectomy soon after diagnosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogen: to maintain sexual maturation and breast development</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pregnancy can be achieved with IVF with donor oocytes</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: 45 XO gonadal dysgenesis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is Turner syndrome</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B: 46 XX gonadal dysgenesis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There is no particular name but it includes ovarian dysgenesis leading to hypergonadotropic hypogonadism</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D: 46 XXY gonadal dysgenesis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is Klinefelter syndrome</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">46 XY complete gonadal dysgenesis is Swyer syndrome</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 166102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41605,
      "choices": [
        {
          "id": 166104,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased testosterone/ DHT ratio</span></span></span></p>"
        },
        {
          "id": 166105,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased testosterone/ DHT ratio</span></span></span></p>"
        },
        {
          "id": 166106,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No change in the testosterone/ DHT ratio</span></span></span></p>"
        },
        {
          "id": 166107,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absent testosterone levels</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 14-year-old girl is brought to the OPD by her mother. She is of normal height, at the top of her class but her mother is concerned because of a sudden increase in hair growth and hoarseness of voice. She also mentions that she hasn&rsquo;t yet attained menarche. On examination, there is absent breast development and minimal presence of pubic and axillary hair. There is also increased facial hair growth and on local examination, there is an enlarged clitoris. An ultrasound reveals an absent uterus with the presence of gonad-like structures in the inguinal canal. Suspecting 5 alpha reductase deficiency, testosterone and DHT level is done. What is the expected finding in 5 alpha reductase deficiency?</span></span></span></p>",
      "unique_key": "Q3542643",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697576,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Increased testosterone/ DHT ratio</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&alpha;&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reductase Deficiency</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autosomal recessive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Karyotype: 46XY </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Defective conversion of Testosterone to DHT (which is mediated by the enzyme 5 alpha reductase)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Testosterone (in fetal life): causes development of the internal male genitalia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DHT is responsible for external male genital development: Hence this does not develop as the enzyme mediating the conversion is absent/ deficient </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Classical presentation:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">External genitalia: predominantly Female at birth</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Internal genitalia: Male (The epididymis, the vas deferens, seminal vesicles and ejaculatory ducts form but empty into a short blind vagina)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Testis: Located in the inguinal canal</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At Puberty: Virilization of varying degrees</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Affected men develop a normal muscle mass, libido, deepening of voice (Testosterone dependent) but have less body hair, less temporal hairline recession, no acne (All these are DHT dependent) </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis: </span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Suspect in infants with genital ambiguity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Suspect in adolescence with the characteristic phenotype and a serum hormonal profile showing <strong>normal male level testosterone and an increased testosterone/ DHT ratio</strong></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 166104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19014,
      "choices": [
        {
          "id": 76016,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH agonists</span></span></span></p>"
        },
        {
          "id": 76017,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laparoscopic hysterectomy</span></span></span></p>"
        },
        {
          "id": 76018,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laparoscopic myomectomy</span></span></span></p>"
        },
        {
          "id": 76019,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Review ultrasound after 1 year</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year old presents for a routine gynecological checkup. She is having regular cycles with normal flow and mild dysmenorrhea on the 1<sup>st</sup> day. She is a non-smoker and has no history of hypertension or diabetes. Her last pap smear was 2 years back which was reported to be normal. An ultrasound shows the presence of a 4 x 4 cm intramural fibroid with a sub-serosal component. She is very anxious and seeks your opinion on what should be done. </span></span></p>",
      "unique_key": "Q1206651",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697577,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Review ultrasound after 1 year</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is an asymptomatic fibroid</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Asymptomatic fibroids (irrespective of size) do not require treatment and just need an annual evaluation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Symptomatic fibroids can be managed medically/ surgically/ non invasive techniques based on several factors like the age of the patient, the size and number of fibroids and the location of fibroid</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Other Options</em></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Option A:&nbsp;</em></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH agonists: This can be given to women with symptomatic fibroids to reduce the size and also control symptoms. It is also given to women pre-operatively to reduce the size of the fibroid</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B:</strong>&nbsp;Laparoscopic hysterectomy: There is no indication for surgical managment in a patient with an asymptomatic fibroid. Following menopause, fibroids usually shrink in size due to hypo-estrogenism.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C:</strong>&nbsp;Laparoscopic myomectomy: There is no indication for doing a myomectomy in a patient with an asymptomatic fibroid.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Educational Objective:</em></span></span></strong></p>\r\n\r\n<p><strong><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Management of symotomatic fibroids can be medical or surgical or newer non invasive techniques&nbsp;</em></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Medical Management</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non Hormonal: </span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NSAIDs for pain and heavy bleeding</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-fibrinolytics (Tranexamic acid): For heavy bleeding</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hormonal</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combined OCPS</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SPRMs</span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ulipristal acetate</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mifepristone</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LNG-IUS: in small fibroids NOT distorting the uterine cavity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH agonists</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH antagonists</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Surgical Management</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">a. Myomectomy (Laparoscopic/ Laparotomy/ Hysteroscopic for submucous myomas)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">b. Hysterectomy: Preferred in women who are not wanting future fertility with large/ multiple symptomatic fibroids</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Non invasive</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">a. Magnetic Resonance Guided Focused Ultrasound (MRgFUS)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">b. Uterine artery embolization</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">*Asymptomatic fibroids (irrespective of size) do not require treatment and just need an annual evaluation.</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 232, DC Dutta&rsquo;s textbook of gynecology, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19015,
      "choices": [
        {
          "id": 76020,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Advise MTP</span></span></span></p>"
        },
        {
          "id": 76021,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laparoscopic myomectomy</span></span></span></p>"
        },
        {
          "id": 76022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Analgesia and hydration</span></span></span></p>"
        },
        {
          "id": 76023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hysterotomy and myomectomy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 23-year primi is presents at 16 weeks pregnancy with acute abdominal pain. On examination, the uterus is 20 weeks size and there is tenderness over the abdomen. An ultrasound reveals, a 6 cm fibroid in the anterior wall. What is the next best management?</span></span></span></p>",
      "unique_key": "Q2036088",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697578,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Analgesia and hydration</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is most likely a red degeneration of fibroid which is commonly seen in pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Red degeneration occurs in a large fibroid mainly during 2<sup>nd</sup> half of pregnancy and puerperium. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pain is the predominant symptom.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment is supportive and pain usually settles with analgesics and anti-inflammatory drugs</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: Advise MTP: This is usually never advised in red degeneration as majority of red degenerations will symotomatically improve</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B: Laparoscopic myomectomy: Not indicated during pregnancy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C: Hysterotomy and myomectomy: Nor indicated in red degeneration of fibroid</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Red degeneration occurs in a large fibroid mainly during 2<sup>nd</sup> half of pregnancy and puerperium. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pain is the predominant symptom.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment is supportive and pain usually settles with analgesics and anti-inflammatory drugs</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 227, DC Dutta&rsquo;s Textbook of gynecology</span></strong></span></span></p>",
      "correct_choice_id": 76022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19016,
      "choices": [
        {
          "id": 76024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcific degeneration</span></span></span></p>"
        },
        {
          "id": 76025,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fatty degeneration</span></span></span></p>"
        },
        {
          "id": 76026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyaline degeneration</span></span></span></p>"
        },
        {
          "id": 76027,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Red degeneration</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common degeneration seen in uterine fibroids is</span></span></p>",
      "unique_key": "Q8396577",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697579,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Hyaline degeneration</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common type of degeneration in fibroids is hyaline degeneration</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Red degeneration, calcific degeneration and fatty degeneration are other kinds of degeneration in fibroids&nbsp;</span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common type of degeneration in fibroids is hyaline degeneration</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 227, DC Dutta&rsquo;s Textbook of gynecology</span></strong></span></span></p>",
      "correct_choice_id": 76026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19017,
      "choices": [
        {
          "id": 76028,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenomyosis</span></span></span></p>"
        },
        {
          "id": 76029,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibroid polyp</span></span></span></p>"
        },
        {
          "id": 76030,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leiomyoma</span></span></span></p>"
        },
        {
          "id": 76031,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ovarian mass</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year nulliparous woman presents to the OPD. She complains of pelvic heaviness. She also mentions that her periods have been increasingly heavy in amount and she has to take a pain killer on the 1<sup>st</sup> 2 days of her period due to excessive pain. The periods are otherwise regular. On examination, there is an irregular mass palpated abdominally which is about the size of an 18 weeks gravid uterus. On bimanual exam, the same irregular mass is felt and there is transmitted mobility. What is the possible diagnosis?</span></span></p>",
      "unique_key": "Q1032409",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697580,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Leiomyoma</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This patient has symptoms of heavy menstrual bleed and dysmenorrhea which are seen in adenomyosis, fibroids (leiomyoma) and polyp. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">On examination, this is&nbsp; a fibroid (probably multiple fibroids)</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The uterus is significantly enlarged and irregular</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The woman is nulliparous</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Other Options:</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In adenomyosis, the uterus is regularly enlarged (max size of 12-14 weeks size)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In fibroid polyp, the uterus will be normal or slightly enlarged in size and on speculum exam, a polyp may be seen extruding from the os. Fibroid polyps usually present with inter menstrual bleeding or irregular bleeding</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In ovarian mass, there usually won&#39;t be any menstrual symptoms, also transmitted mobility will be absent (i.e. on moving the mass, the cervix will not be felt to move)</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C/f of fibroid uterus</span></span></span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Symptoms</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Menorrhagia</span></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Dysmenorrhoea</em></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Infertility</em></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Abdominal mass and pressure symptoms</em></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Signs:</em></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Uterus regularly enlarged (single fibroid) or irregularly enlarged (multiple fibroids)</em></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Transmitted mobility is felt in a fibroid&nbsp;</em></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 76030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19019,
      "choices": [
        {
          "id": 76036,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laparoscopic myomectomy</span></span></span></p>"
        },
        {
          "id": 76037,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hysteroscopic myomectomy</span></span></span></p>"
        },
        {
          "id": 76038,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reassurance</span></span></span></p>"
        },
        {
          "id": 76039,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH agonists</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year woman who is anxious to conceive visits the OPD with her husband. They have been trying to conceive for 2 years. She has regular periods with heavy flow. There is associated dysmenorrhea. A transvaginal scan shows a submucosal fibroid of about 2 cm in size. What is the best management option?</span></span></p>",
      "unique_key": "Q8969315",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Hysteroscopic myomectomy</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This patient is infertile and has a submucosal fibroid. The fibroid has to be removed. Type 0 and 1 submucosal fibroids are best removed hysteroscopically</span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A:</strong> Laparoscopic myomectomy: Is indicated usually in intramural and subserosal fibroids</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B:</strong> Reassurance: Whenever an infertile patient has a submucosal fibroid or a large intra-mural fibroid, it has to be removed.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C:</strong> GnRH agonist: Could have been tried if the patient did not have infertility.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indications of myomectomy in infertility are:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Submucous fibroids</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large intramural fibroids distorting the cavity.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intramural fibroids &gt; 5cm</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Submucosal fibroids are best removed hysteroscopically (Esp type 0 and type 1)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19021,
      "choices": [
        {
          "id": 76044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At the infundibulopelvic ligaments</span></span></span></p>"
        },
        {
          "id": 76045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At the level of round ligaments</span></span></span></p>"
        },
        {
          "id": 76046,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At the level of the internal os</span></span></span></p>"
        },
        {
          "id": 76047,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At the level of the fibroid </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are assisting the surgeon in an abdominal myomectomy. The surgeon applies this instrument. Where would this be applied?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/1.jpg\" style=\"height:313px; width:400px\" /></span></span></p>",
      "unique_key": "Q3843026",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697582,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. At the level of the internal os</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation</span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is a Bonney&rsquo;s myomectomy clamp</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is applied at the level of the uterine arteries&nbsp; (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></span></strong></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/1.jpg\" style=\"height:313px; width:400px\" /></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is a Bonney&rsquo;s myomectomy clamp</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is applied at the level of the uterine arteries&nbsp; (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 527, DC Dutta&rsquo;s Textbook of Gynecology 7<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 76046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19023,
      "choices": [
        {
          "id": 76052,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ovarian cystectomy</span></span></span></span></p>"
        },
        {
          "id": 76053,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Myomectomy</span></span></span></span></p>"
        },
        {
          "id": 76054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Tubal recanalization</span></span></span></span></p>"
        },
        {
          "id": 76055,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Vaginal hysterectomy</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The instrument shown below is useful in which surgery?</span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/2.jpg\" style=\"height:171px; width:294px\" /></span></span></span></p>",
      "unique_key": "Q2878438",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697583,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. Myomectomy</span></span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation:</span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The image is of a myoma screw.&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is an instrument used in myomectomy.&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Myomectomy is a conservative surgery for fibroid uterus</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It can be performed via laparotomy or laparoscopically</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Risk of bleeding. This can be reduced</span></span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Preoperatively</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">GnRH agonists: They also reduce the size of the fibroid&nbsp;</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Correction of anemia/ blood transfusion</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Uterine Artery Embolization</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Intra-operatively</span></span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Use of Bonney&rsquo;s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries)</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Use of vasopressin: injected along the planned serosal incision</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><strong>Educational Objective:&nbsp;</strong></em></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/2.jpg\" style=\"height:171px; width:294px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The image is of a myoma screw.&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is an instrument used in myomectomy.&nbsp;</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 946, William&rsquo;s Gynecology 3<sup>rd</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 76053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19024,
      "choices": [
        {
          "id": 76056,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Bonnie&rsquo;s clamp during surgery</span></span></span></span></p>"
        },
        {
          "id": 76057,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Bilateral Uterine artery ligation</span></span></span></span></p>"
        },
        {
          "id": 76058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ligation of vessels over the surface of the myoma</span></span></span></span></p>"
        },
        {
          "id": 76059,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Use of vasopressin along the planned serosal incision</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 36-year lady presents with menorrhagia. On evaluation she is found to have a large intramural fibroid. A myomectomy is planned. All are beneficial in reducing blood loss during surgery except?</span></span></span></p>",
      "unique_key": "Q7989486",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697584,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C. Ligation of vessels over the surface of the myoma</span></span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:&nbsp;</span></span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em>Ligation of vessels over the surface of the myoma will not help reduce blood loss significantly during&nbsp; a myomectomy</em></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Myomectomy is a conservative surgery for fibroid uterus</span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It can be performed via laparotomy or laparoscopically</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Risk of bleeding. This can be reduced</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Preoperatively</span></span></span></span>\r\n\t<ul style=\"margin-left:40px\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">GnRH agonists: They also reduce the size of the fibroid&nbsp;</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Correction of anemia/ blood transfusion</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Uterine Artery Embolization</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Intra-operatively</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Use of Bonney&rsquo;s uterine clamp/ uterine tourniquet (tied at the level of the uterine arteries)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Use of vasopressin: injected along the planned serosal incision</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 946, William&rsquo;s Gynecology 3<sup>rd</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 76058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19028,
      "choices": [
        {
          "id": 76072,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Endometrial Biopsy</span></span></span></span></span></p>"
        },
        {
          "id": 76073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">LNG-IUD</span></span></span></span></span></p>"
        },
        {
          "id": 76074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Myomectomy</span></span></span></span></span></p>"
        },
        {
          "id": 76075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Hysterectomy</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A 45-year lady presents with heavy menstrual bleeding for 3 months. On examination, she does not appear to be pale. Her BP is 150/90mmHg. An abdominal and pelvic exam is normal. A transvaginal scan shows a 2 cm Intramural fibroid and an endometrial thickness of 15mm. both the ovaries appear normal &nbsp;What is the next best step?</span></span></span></span></p>",
      "unique_key": "Q1082991",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Ans. A. Endometrial Biopsy</span></span></span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Explanation:</span></span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">At 45y, heavy bleeding during periods could be because of endometrial hyperplasia or malignancy. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">It&nbsp;is important to rule out precancerous lesions and cancerous lesions at this age. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">A small 2 cm fibroid is unlikely to be the cause of her symptoms but her increased endometrial thickness on the ultrasound (15 mm is a thick endometrium for her age) could be alikely cause.&nbsp;</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Th&nbsp;is thickened endometrium&nbsp;warrants an endometrial biopsy to tule out endometrial hyperplasia and cancer</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Educational Objective:</span></span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Fibroids and endometrial hyperplasia/ malignancy usually coexist as both are hyperestrogenic states</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Women in the peri-menopausal age group with fibroids with heavy menstrual bleeding should be evaluated for endometrial hyperplasia and cancer</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 946, William&rsquo;s Gynecology 3<sup>rd</sup> &nbsp;edition</span></span></strong></span></span></p>",
      "correct_choice_id": 76072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19034,
      "choices": [
        {
          "id": 76096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Type 0</span></span></span></span></span></p>"
        },
        {
          "id": 76097,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Type 1</span></span></span></span></span></p>"
        },
        {
          "id": 76098,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Type 2</span></span></span></span></span></p>"
        },
        {
          "id": 76099,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Type 3</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A 34-year with menorrhagia is diagnosed to have a submucosal fibroid with &lt; 50% protrusion in the endometrial cavity. She is FIGO type?</span></span></span></p>",
      "unique_key": "Q3076407",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697586,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Ans. C. Type 2</span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&lt;50% protrusion in the endometrial cavity means &gt;50% is intramural. Hence the answer is type 2.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\"><u>Explanation</u>:</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">FIGO Classification of fibroids is as shown:</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/fibroid-2-1_UGbfyjY.jpg\" style=\"height:437px; width:1000px\" /></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Ref: </span></span></span></strong><a href=\"https://obgyn.onlinelibrary.wiley.com/doi/10.1016/j.ijgo.2010.11.011\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\">https://obgyn.onlinelibrary.wiley.com/doi/10.1016/j.ijgo.2010.11.011</span></span></strong></a></span></span></p>",
      "correct_choice_id": 76098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19156,
      "choices": [
        {
          "id": 76584,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal</span></span></span></p>"
        },
        {
          "id": 76585,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Asherman syndrome</span></span></span></p>"
        },
        {
          "id": 76586,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B/l tubal block</span></span></span></p>"
        },
        {
          "id": 76587,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Submucosal fibroid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is your interpretation of the following hysterosalpingogram?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture3_6tRXoo1.jpg\" style=\"height:224px; width:350px\" /></p>",
      "unique_key": "Q2639996",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697587,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Submucosal fibroid</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This HSG shows a large well defined lesion in the uterus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is most likely a submucosal fibroid</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal</span></strong>: A normal HSG would show a regular, symmetrically shaped uterine cavity without any filling defects or irregularities. The fallopian tubes would be visible, with the contrast material flowing freely through them, indicating patency . No obstructions or unusual shapes should be present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman syndrome</span></strong>: This condition is characterized by the presence of intrauterine adhesions or scar tissue. On an HSG, Asherman syndrome may present as irregular filling defects within the uterine cavity or as a generally diminished size of the uterine cavity, depending on the severity of the adhesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral tubal block (B/l tubal block)</span></strong>: In cases of bilateral tubal blockage, an HSG would show a lack of contrast material passing through one or both fallopian tubes ie. absence of free spill.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Submucosal fibroid</span></strong>: They are fibroids that grow just beneath the lining of the uterine cavity. On an HSG, these would appear as filling defects within the uterine cavity. They might show as smooth, round, or lobulated contours projecting into the cavity, disrupting the otherwise smooth and regular shape of the uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: HSG is a valuable diagnostic tool in assessing the shape of the uterine cavity and the patency of the fallopian tubes, which are crucial in evaluating female fertility. On an HSG, submucosal fibroids &nbsp;would appear as filling defects within the uterine cavity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 440, Williams Gynecology 3<sup>rd</sup> editionQuestion ID:19156</span></strong></span></span></p>",
      "correct_choice_id": 76587,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19157,
      "choices": [
        {
          "id": 76588,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterosalpingography</span></p>"
        },
        {
          "id": 76589,
          "text": "<p><span style=\"font-size:16px;\">Laparoscopic </span><span style=\"background-color:transparent;font-size:16px;\">chrompertubation</span></p>"
        },
        {
          "id": 76590,
          "text": "<p><span style=\"font-size:12.0pt;\">Saline infusion sonography</span></p>"
        },
        {
          "id": 76591,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnetic resonance imaging</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is the gold standard technique for tubal evaluation?</span></p>",
      "unique_key": "Q5866972",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697588,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Laparoscopic evaluation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The following are tests done for tubal patency</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">HSG (usually a preliminary test)</span></li><li><span style=\"font-size:16px;\">Laparoscopic Chromotubation (Gold standard)</span></li><li><span style=\"font-size:16px;\">Saline salpingography (better for intra uterine lesions)</span></li><li><span style=\"font-size:16px;\">Others</span><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:16px;\">HyCoSy</span></li><li><span style=\"font-size:16px;\">Falloposcopy</span></li></ol></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Let's review each option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A.</strong>&nbsp;<strong>Hysterosalpingography (HSG)</strong>: This is a radiographic technique where a contrast dye is injected into the uterine cavity, and X-ray images are taken to visualize the uterus and fallopian tubes. HSG is primarily used for evaluating the internal shape of the uterus and the patency of the fallopian tubes. While it's a commonly used first-line investigation for tubal assessment in infertility evaluations, it provides limited information about the external contour of the tubes and surrounding structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.</strong>&nbsp;<strong>Laparoscopic </strong></span><span style=\"background-color:transparent;font-size:16px;\"><strong>chrompertubation</strong></span><span style=\"font-size:16px;\">: Laparoscopy is considered the gold standard for tubal evaluation. It's a minimally invasive surgical procedure that provides a direct view of the pelvic organs, including the fallopian tubes. Laparoscopy not only allows for the assessment of tubal patency (often combined with chromopertubation, where a dye is passed through the tubes) but also enables visualization of the outer aspects of the tubes and the detection of other pelvic pathologies like endometriosis, adhesions, or fibroids that might affect tubal function. Its main limitation is that it's an invasive procedure requiring anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C</strong>.&nbsp;<strong>Saline Infusion Sonography (SIS)</strong>: SIS involves the infusion of saline into the uterine cavity during ultrasound examination. This technique &nbsp;can be used to asses tubal patency, &nbsp;it also enhances the visualization of the uterine cavity and can be useful in detecting abnormalities like polyps or fibroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.</strong>&nbsp;<strong>Magnetic Resonance Imaging (MRI)</strong>: MRI can provide detailed images of the pelvic organs, including the uterus and fallopian tubes, without using ionizing radiation. It's particularly useful in assessing uterine anomalies and some types of fibroids. However, MRI is less commonly used for direct assessment of tubal patency or minor tubal abnormalities compared to laparoscopy or HSG.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>: Laparoscopic evaluation, as the gold standard, offers the most comprehensive assessment of the fallopian tubes and surrounding pelvic anatomy. However, other less invasive techniques like HSG and SIS also play important roles in initial assessments, especially in infertility workups. MRI, while offering excellent soft tissue contrast, is less specific for tubal patency</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Page 441, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 76589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19158,
      "choices": [
        {
          "id": 76592,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Azoospermia</span></span></p>"
        },
        {
          "id": 76593,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Oligospermia</span></span></p>"
        },
        {
          "id": 76594,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teratospermia </span></span></p>"
        },
        {
          "id": 76595,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low semen volume </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In treating hypertension, with beta blockers, which of the following semen parameter abnormalities may be seen?</span></span></p>",
      "unique_key": "Q3877039",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697589,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Low semen volume</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low semen volume often simply reflects incomplete specimen collection or short abstinence interval. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">However, it may indicate partial vas deferens obstruction or retrograde ejaculation. </span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Partial or complete vas deferens obstruction may be caused by infection, tumor, prior testicular or inguinal surgery, or trauma. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retrograde ejaculation follows failed closure of the bladder neck during ejaculation and allows seminal fluid to flow backward into the bladder. Retrograde ejaculation is suspected in men with</span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diabetes mellitus</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spinal cord damage</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prior prostate or other retroperitoneal surgery that may have damaged nerves </span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medications (&beta;-blockers) </span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A postejaculatory urinalysis can detect sperm in the bladder and confirm the diagnosis. If urine is properly alkalinized, these sperm are viable and can be retrieved to achieve pregnancy</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us explore the options given:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Azoospermia</span></strong>: This refers to the complete absence of sperm in the semen. While certain medications and health conditions can lead to azoospermia, beta-blockers are not typically associated with this severe a level of spermatogenic failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligospermia</span></strong>: Oligospermia means a lower than normal sperm count. Some medications and health issues can lead to oligospermia, but beta-blockers are not commonly linked to significant decreases in sperm count.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teratospermia</span></strong>: Teratospermia is characterized by a high percentage of abnormally shaped sperm in the semen. This condition can be caused by various factors, including genetic defects, lifestyle choices, and exposure to certain chemicals or radiation. Beta-blockers are not known to specifically cause teratospermia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low semen volume</span></strong> (Correct Answer): Beta-blockers can lead to a decrease in semen volume. This effect is thought to be related to the general inhibitory effects of beta-blockers on the sympathetic nervous system, which plays a role in seminal emission. As a result, men taking beta-blockers may experience a reduction in the volume of ejaculate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While beta-blockers are effective in treating hypertension and various cardiovascular conditions, they can have side effects on sexual and reproductive health, such as reduced semen volume. It&#39;s important for healthcare providers to be aware of these potential side effects and discuss them with patients who are on long-term beta-blocker therapy, especially those who are concerned about fertility. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 443, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19159,
      "choices": [
        {
          "id": 76596,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sperm count </span></span></span></p>"
        },
        {
          "id": 76597,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Semen volume </span></span></span></p>"
        },
        {
          "id": 76598,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sperm motility </span></span></span></p>"
        },
        {
          "id": 76599,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sperm morphology</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Asthenospermia refers to which of the following semen abnormalities? </span></span></span></p>",
      "unique_key": "Q2239435",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697590,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Sperm motility</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-133945.jpg\" style=\"height:557px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s go through each option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Count</span></strong>: This refers to the concentration of sperm in a given volume of ejaculate. When the sperm count is lower than normal, it is termed oligospermia. Asthenospermia is not related to the count or concentration of sperm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Semen Volume</span></strong>: This is the total volume of the ejaculated fluid. A low semen volume can be due to various causes, including hormonal imbalances or blockages in the reproductive tract. However, asthenospermia does not pertain to the volume of semen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Motility</span></strong> (Correct Answer): Asthenospermia is specifically related to sperm motility, which refers to the ability of sperm to move efficiently. This is an important factor in fertility since sperm must be able to swim through the female reproductive tract to reach and fertilize the egg. Asthenospermia is characterized by a decreased percentage of motile sperm in the semen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Morphology</span></strong>: This refers to the size and shape of sperm. Abnormalities in sperm morphology (teratospermia) can impact the ability of sperm to fertilize an egg. Asthenospermia, however, is specifically about the movement ability of sperm, not their shape or size.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The key educational objective is to understand the different parameters evaluated in a semen analysis and their significance in assessing male fertility. Asthenospermia, a condition marked by reduced sperm motility, is an important factor to consider in the evaluation of male infertility. Recognizing the distinctions between sperm count, motility, volume, and morphology is crucial for healthcare providers in diagnosing and managing fertility issues in men. This knowledge is particularly relevant in the fields of urology, reproductive endocrinology, and andrology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 443, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76598,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19161,
      "choices": [
        {
          "id": 76604,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zona penetration assay </span></span></span></p>"
        },
        {
          "id": 76605,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DNA fragmentation index </span></span></span></p>"
        },
        {
          "id": 76606,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoosmotic swelling test </span></span></span></p>"
        },
        {
          "id": 76607,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mannose fluorescence assay </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following tests can differentiate between dead and nonmotile sperm? </span></span></span></p>",
      "unique_key": "Q8494360",
      "question_audio": null,
      "question_video": null,
      "map_id": 19697591,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hypoosmotic swelling test</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased sperm motility is termed asthenospermia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Motility can be classified as</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rapid (grade 3 to 4)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Slow (grade 2)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nonprogressive (grade 0 to 1) movement. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total progressive motility is the percentage of sperm exhibiting forward movement (grades 2 to 4). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes of Asthenospermia: Prolonged abstinence, Antisperm antibodies, genital tract infections and varicocele. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To differentiate between dead and nonmotile sperm, <strong>a hypoosmotic swelling test</strong> can be performed. Unlike dead sperm, living sperm can maintain an osmotic gradient. Thus, when mixed with a hypoosmotic solution, living, nonmotile sperm with normal membrane function swell and coil as fluid is absorbed. Once identified, these viable sperm may be used for intracytoplasmic sperm injection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Let us look at the other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DNA Fragmentation test measures the amount of damaged DNA in sperm. Sperm DNA fragmentation (SDF) can be caused by extrinsic factors (<em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">i.e.</span></em>, heat exposure, smoking, environmental pollutants, and chemotherapeutics) as well as intrinsic factors (<em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">i.e.</span></em>, defective germ cell maturation, abortive apoptosis, and oxidative stress)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The sperm penetration assay, or zona-free hamster oocyte penetration assay is utilized to measure the ability of sperm to undergo capacitation, fuse with the egg membrane and decondense the sperm head within the cytoplasm of the oocyte resulting in the formation of the male pronucleus. The test is scored by calculation the percentage of ova that are penetrated or the average number of sperm penetrations per ovum. It&#39;s used to evaluate the fertilizing capability of sperm but does not differentiate between dead and nonmotile sperm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannose Fluorescence Assay is used to assess the binding of sperm to mannose, a component of the egg&#39;s outer covering. It evaluates a specific aspect of sperm function </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">related to fertilization but does not differentiate between dead and nonmotile sperm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The hypoosmotic swelling test for assessing sperm viability, helps to differentiate between dead and nonmotile sperm.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 444, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></p>",
      "correct_choice_id": 76606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}